BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy2626
(355 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 135 bits (339), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 106/374 (28%), Positives = 162/374 (43%), Gaps = 50/374 (13%)
Query: 4 YYDDSLCSTPRNEIGTCISIRQCRYLYDILNNERNNPRAV-----QYVKNSHCGLEGRLP 58
Y DD C+TP + G C+ CR + + L + + V Y++ + CG +
Sbjct: 28 YADD--CTTPDGDQGQCMPFSSCRTIEERLTEAQKAGQKVPADYASYLQKALCGEFNGVR 85
Query: 59 KVCCPQHTLTNDQXXXXXXXXXXXXGAFTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQ 118
CCP + ++ L +N +CG N S+R+ G +
Sbjct: 86 HFCCPSANIQHNSK-------------VMSLFKDENFDCG-NFL--SQRVSNGYEVKLSS 129
Query: 119 WPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSI 177
PWMA + R + G+ ++CGGA+I++RY+LTAAHCV YE + H S
Sbjct: 130 RPWMALL-----RYQQFGESRFLCGGAMISERYILTAAHCVHGLQNDLYEIRLGEHRIST 184
Query: 178 DLEDTSSG---------VSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPICL 228
+ + G V++ IE+ +IHE+Y + ++DIAL +L P I+PICL
Sbjct: 185 EEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIMHDIALLKLNRSVPFQKHIKPICL 244
Query: 229 PYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATINE 288
P L+ + + T FV GWG+T G S L + + C Q Y +
Sbjct: 245 PITDELKEKAEQISTYFVTGWGTTE-NGSSSDVLLQANVPLQPRSACSQA---YRRAVPL 300
Query: 289 NILCAGVLXXXXXXXXXXXXXPLMYPLD------TKYYIIGVVSYG-KKCAEVGFPGVYT 341
+ LC G PL P K G+VS G C ++ PG+YT
Sbjct: 301 SQLCVGG-GDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYT 359
Query: 342 RVTNYIQWIADNIS 355
V Y+QWI D ++
Sbjct: 360 NVGEYVQWITDTMA 373
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 77/249 (30%), Positives = 126/249 (50%), Gaps = 17/249 (6%)
Query: 103 NSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPD 162
N+ RIVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+
Sbjct: 11 NNLTRIVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-- 60
Query: 163 TTGEYEPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
+ + + V VG + E G ++ E+E I H ++T DIA+ RL+
Sbjct: 61 ---QAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRM 117
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+ P CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S+
Sbjct: 118 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSS 176
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
+ I +N+ CAG P + Y++ G+VS+G+ CA G G+YT
Sbjct: 177 F--IITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYT 234
Query: 342 RVTNYIQWI 350
+VT +++WI
Sbjct: 235 KVTAFLKWI 243
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 126 bits (316), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 129/247 (52%), Gaps = 14/247 (5%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S G+WPW ++ K+ +R +CGG+LI ++VLTAAHC D
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRH------LCGGSLIGHQWVLTAAHCF--DGLPLQ 52
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + ++ G ++L D + +I+ IIH+ Y + +DIAL +L+ ++ +PI
Sbjct: 53 DVWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPI 112
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP + S ++ +V GWG + +G + L+ V I +V N +C++ + +Y I
Sbjct: 113 SLPSKGD-TSTIY--TNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KI 167
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+ ++CAG PL+ + + ++G+ S+G+ CA PGVYT+V Y
Sbjct: 168 TQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEY 227
Query: 347 IQWIADN 353
+ WI +
Sbjct: 228 MDWILEK 234
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 125 bits (314), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 19/246 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG+ S G WPW+ A+ F ++ +CG +L+++ ++++AAHCV E
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQ---------VCGASLVSRDWLVSAAHCVYGRNM-EP 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIE---IERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQ 224
+ +G + + + IE I++ +I+ Y RK NDIA+ L +D IQ
Sbjct: 51 SKWKAVLG-LHMASNLTSPQIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQ 109
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
PICLP + + + +AGWG+ +++G + L+ + ++ N KC+Q Y
Sbjct: 110 PICLPEENQV---FPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEY-- 164
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
I EN++CAG PLM + ++ + GV S+G +CA PGVY RV
Sbjct: 165 NITENMVCAGYEAGGVDSCQGDSGGPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVP 224
Query: 345 NYIQWI 350
+ +WI
Sbjct: 225 RFTEWI 230
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 125 bits (313), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 75/246 (30%), Positives = 129/246 (52%), Gaps = 14/246 (5%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S G+WPW ++ K+ +R +CGG+LI ++VLTAAHC D
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRH------LCGGSLIGHQWVLTAAHCF--DGLPLQ 52
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + ++ G ++L D + +I+ IIH+ Y + +DIAL +L+ ++ +PI
Sbjct: 53 DVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPI 112
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP + S ++ +V GWG + +G + L+ V I +V N +C++ + +Y I
Sbjct: 113 SLPSKGD-TSTIY--TNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KI 167
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+ ++CAG PL+ + + ++G+ S+G+ CA PGVYT+V Y
Sbjct: 168 TQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEY 227
Query: 347 IQWIAD 352
+ WI +
Sbjct: 228 MDWILE 233
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 125 bits (313), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 85/266 (31%), Positives = 128/266 (48%), Gaps = 27/266 (10%)
Query: 94 NNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVL 153
+NEC RIVGGT S RG+WPW + +R +CGG++I +++L
Sbjct: 377 DNECTTKI---KPRIVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWIL 427
Query: 154 TAAHCVSPDTTGEYEPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLND 207
TAAHC G P I+ V S L EDTS ++ IIH+QY A D
Sbjct: 428 TAAHCFY----GVESPKILRVYSGILNQSEIKEDTSF---FGVQEIIIHDQYKMAESGYD 480
Query: 208 IALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQI 267
IAL +L +D +PICLP + R+ ++ +V GWG R + L+ +I
Sbjct: 481 IALLKLETTVNYTDSQRPICLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKI 537
Query: 268 SVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSY 327
+V N +C++ + G I ++CAG PL + ++++G+ S+
Sbjct: 538 PLVTNEECQKRYR--GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSW 595
Query: 328 GKKCAEVGFPGVYTRVTNYIQWIADN 353
G+ CA+ PGVYT V Y+ WI +
Sbjct: 596 GEGCAQRERPGVYTNVVEYVDWILEK 621
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 90/262 (34%), Positives = 128/262 (48%), Gaps = 25/262 (9%)
Query: 97 CGVNAF--NSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEW--MCGGALITKRYV 152
CG F N S R+VGG + WPW ++ R N W CGG LIT +V
Sbjct: 1 CGAPIFQPNLSARVVGGEDAIPHSWPWQ----ISLQYLRDN---TWRHTCGGTLITPNHV 53
Query: 153 LTAAHCVSPDTTGEYEPYIVHVG--SIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIAL 210
LTAAHC+S T Y V +G ++++ED + + + ++ +HE++ S NDIAL
Sbjct: 54 LTAAHCISNTLT-----YRVALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIAL 108
Query: 211 FRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVV 270
+L E L D IQ CLP + +L L + FV GWG GP++ +L+ VV
Sbjct: 109 IKLAETVELGDTIQVACLPSEGSL---LPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVV 165
Query: 271 DNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK- 329
D C Q +G T+ E ++CAG PL D ++ + G+VS+G
Sbjct: 166 DYATCSQ-RDWWGTTVKETMVCAGG-DGVISACNGDSGGPLNCQADGQWDVRGIVSFGSG 223
Query: 330 -KCAEVGFPGVYTRVTNYIQWI 350
C P V+TRV+ YI WI
Sbjct: 224 LSCNTFKKPTVFTRVSAYIDWI 245
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 123 bits (309), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PICLP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPICLPSKGD-RNVIY--TDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 122/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG G+ PW A + N + E CGG ++ + YVLTAAHC+ +
Sbjct: 1 IVGGRDCAEGECPWQALL--------VNEENEGFCGGTILNEFYVLTAAHCLH-----QA 47
Query: 168 EPYIVHVGSIDLE-DTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E + + ++ E+E + H ++ DIA+ RL+ + P
Sbjct: 48 KRFTVRVGDRNTEQEEGNEMAHEVEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP + L +KT V+G+G T +G LS L+ +++ VD C+ + S++ TI
Sbjct: 108 CLPEKDWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCK-LSSSF--TI 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
N+ CAG P + Y++ G+VS+G+ CA G GVYT+V+N+
Sbjct: 165 TPNMFCAGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 122 bits (307), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 123/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 122 bits (306), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQSEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PICLP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPICLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 122 bits (306), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIAEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PICLP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPICLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 122 bits (305), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/252 (32%), Positives = 123/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PICLP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPICLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 119 bits (299), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 74/244 (30%), Positives = 122/244 (50%), Gaps = 17/244 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGQECKDGECPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTAAEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
CLP S L +KT V+G+G T +G S +L+ +++ VD C+ + S++ I
Sbjct: 108 CLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCK-LSSSF--II 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+N+ CAG P + Y++ G+VS+G+ CA G G+YT+VT +
Sbjct: 165 TQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAF 224
Query: 347 IQWI 350
++WI
Sbjct: 225 LKWI 228
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 23/254 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
++ G + RG PW + + K + CG LI +VLTAAHC+ E
Sbjct: 1 LIDGKMTRRGDSPWQVVL--------LDSKKKLACGAVLIHPSWVLTAAHCMD-----ES 47
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ +V +G DL + ++I+ +H Y+ + NDIAL L + A LS I PI
Sbjct: 48 KKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPI 107
Query: 227 CLPYDTNLRSELFER-KTPFVAGWGSTVFRGPLSPK-----LRHVQISVVDNPKCRQIFS 280
CLP EL + + V GWG R + + L ++I VV + +C ++ S
Sbjct: 108 CLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMS 167
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVY 340
N ++EN+LCAG+L P++ ++++G+VS+G+ C + GVY
Sbjct: 168 N---MVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVY 224
Query: 341 TRVTNYIQWIADNI 354
T+V+ Y+ WI +I
Sbjct: 225 TKVSRYLDWIHGHI 238
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 119 bits (297), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 23/254 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
++ G + RG PW + + K + CG LI +VLTAAHC+ E
Sbjct: 1 LIDGKMTRRGDSPWQVVL--------LDSKKKLACGAVLIHPSWVLTAAHCMD-----ES 47
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ +V +G DL + ++I+ +H Y+ + NDIAL L + A LS I PI
Sbjct: 48 KKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPI 107
Query: 227 CLPYDTNLRSELFER-KTPFVAGWGSTVFRGPLSPK-----LRHVQISVVDNPKCRQIFS 280
CLP EL + + V GWG R + + L ++I VV + +C ++ S
Sbjct: 108 CLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMS 167
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVY 340
N ++EN+LCAG+L P++ ++++G+VS+G+ C + GVY
Sbjct: 168 N---MVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVY 224
Query: 341 TRVTNYIQWIADNI 354
T+V+ Y+ WI +I
Sbjct: 225 TKVSRYLDWIHGHI 238
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 119 bits (297), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 17/245 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG+ ++ G WPW+ + + R +CG +L++ ++++AAHCV E
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRL---------LCGASLVSSDWLVSAAHCVYGRNL-EP 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIE--IERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ +G + +S ++ I+ +I+ Y RK NDIA+ L +D IQP
Sbjct: 51 SKWTAILGLHMKSNLTSPQTVPRLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQP 110
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT 285
I LP + + + +AGWG+ V++G + L+ + ++ N +C+Q Y
Sbjct: 111 ISLPEENQV---FPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEY--N 165
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
I EN++CAG PLM + ++++ GV S+G +CA PGVY RV+
Sbjct: 166 ITENMICAGYEEGGIDSCQGDSGGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSR 225
Query: 346 YIQWI 350
+ +WI
Sbjct: 226 FTEWI 230
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 119 bits (297), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQSEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 118 bits (296), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQSEIAEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIAEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 122/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQAEIAEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYAD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP + R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLPSKGD-RNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 118 bits (295), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 80/252 (31%), Positives = 121/252 (48%), Gaps = 24/252 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT S RG+WPW + +R +CGG++I +++LTAAHC G
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRH------LCGGSIIGNQWILTAAHCFY----GVE 50
Query: 168 EPYIVHVGSIDL------EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
P I+ V S L EDTS ++ IIH+QY A DIAL +L +D
Sbjct: 51 SPKILRVYSGILNQSEIKEDTSF---FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTD 107
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+PI LP R+ ++ +V GWG R + L+ +I +V N +C++ +
Sbjct: 108 SQRPISLP-SKGERNVIY--TDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYR- 163
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
G I ++CAG PL + ++++G+ S+G+ CA+ PGVYT
Sbjct: 164 -GHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYT 222
Query: 342 RVTNYIQWIADN 353
V Y+ WI +
Sbjct: 223 NVVEYVDWILEK 234
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 114 bits (286), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 122/248 (49%), Gaps = 21/248 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG ++ GQ+PW + NGK + CGG++I +++V+TAAHC+ P
Sbjct: 1 IVGGENAKPGQFPWQVLL---------NGKIDAFCGGSIINEKWVVTAAHCIEPGV---- 47
Query: 168 EPYIVHVGSIDLEDTS-SGVSIEIERPIIHEQY--TSARKLNDIALFRLREDAPLSDLIQ 224
V G + E+T + + R I H Y T + +DIAL L E L+ +
Sbjct: 48 -KITVVAGEYNTEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVT 106
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
PIC+ D + + + +V+GWG RG + L+++++ +VD C +
Sbjct: 107 PICIA-DKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATC---LRSTKF 162
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT+V+
Sbjct: 163 TIYSNMFCAGFHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTKVS 222
Query: 345 NYIQWIAD 352
Y+ WI +
Sbjct: 223 RYVNWIKE 230
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 80/253 (31%), Positives = 123/253 (48%), Gaps = 22/253 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG + WPW ++ + N CGG LI +VLTAAHC+S T
Sbjct: 1 VVGGEDARPHSWPWQISLQY-----LKNDTWRHTCGGTLIASNFVLTAAHCISNTRT--- 52
Query: 168 EPYIVHVG--SIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
Y V VG ++++ED + + ++ +H+++ + NDIAL +L E LSD IQ
Sbjct: 53 --YRVAVGKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTIQV 110
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
CLP + L + P +V GWG GP++ KL+ VVD+ C +I +G
Sbjct: 111 ACLPE----KDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRI-DWWGF 165
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDT-KYYIIGVVSYGKK--CAEVGFPGVYT 341
+ + ++CAG PL L+ + + G+VS+G + C P VYT
Sbjct: 166 RVKKTMVCAGG-DGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYT 224
Query: 342 RVTNYIQWIADNI 354
RV+ YI WI + +
Sbjct: 225 RVSAYIDWINEKM 237
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 25/275 (9%)
Query: 95 NECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
N+CG + +I+ G + ++PW A IG+K ++ ++ CGG+LI RY++T
Sbjct: 12 NDCGYQV--EADKILNGDDTVPEEFPWTAMIGYK----NSSNFEQFACGGSLINNRYIVT 65
Query: 155 AAHCVSPDTT-----------GEYEPYIVH--VGSIDLEDTSSGVSIEIERPIIHEQYTS 201
AAHCV+ GE+ G++ + + + IE I H Y
Sbjct: 66 AAHCVAGRVLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVD 125
Query: 202 ARK--LNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
K +DIAL RL ++ I+P+CLP N ++ +R T V GWG T G S
Sbjct: 126 GSKDRYHDIALIRLNRQVEFTNYIRPVCLP-QPNEEVQVGQRLT--VVGWGRTE-TGQYS 181
Query: 260 PKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
+ + + VV +C + F G + + LCAG L + ++
Sbjct: 182 TIKQKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAGGEKAKDSCGGDSGGPLLAERANQQF 241
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
++ G+VS+G C G+PG+YT+V Y WI NI
Sbjct: 242 FLEGLVSFGATCGTEGWPGIYTKVGKYRDWIEGNI 276
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 112 bits (280), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 25/258 (9%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
RIVGG + G+WPW ++ R +G +CGG+L++ +VLTAAHC P+
Sbjct: 117 RIVGGRDTSLGRWPWQVSL-------RYDGAH--LCGGSLLSGDWVLTAAHCF-PERNRV 166
Query: 167 YEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY------TSARKLNDIALFRLREDAPLS 220
+ V G++ + + G+ + ++ + H Y S NDIAL L PL+
Sbjct: 167 LSRWRVFAGAV-AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLT 225
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
+ IQP+CLP L + K V GWG+T + G + L+ ++ ++ N C
Sbjct: 226 EYIQPVCLPAAGQ---ALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGA-D 281
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLM----YPLDTKYYIIGVVSYGKKCAEVGF 336
YG I + CAG P + ++ + G+VS+G CA
Sbjct: 282 FYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQK 341
Query: 337 PGVYTRVTNYIQWIADNI 354
PGVYT+V+++ +WI I
Sbjct: 342 PGVYTKVSDFREWIFQAI 359
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 112 bits (280), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 25/258 (9%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
RIVGG + G+WPW ++ R +G +CGG+L++ +VLTAAHC P+
Sbjct: 117 RIVGGRDTSLGRWPWQVSL-------RYDGAH--LCGGSLLSGDWVLTAAHCF-PERNRV 166
Query: 167 YEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY------TSARKLNDIALFRLREDAPLS 220
+ V G++ + + G+ + ++ + H Y S NDIAL L PL+
Sbjct: 167 LSRWRVFAGAV-AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLT 225
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
+ IQP+CLP L + K V GWG+T + G + L+ ++ ++ N C
Sbjct: 226 EYIQPVCLPAAGQ---ALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGA-D 281
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLM----YPLDTKYYIIGVVSYGKKCAEVGF 336
YG I + CAG P + ++ + G+VS+G CA
Sbjct: 282 FYGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQK 341
Query: 337 PGVYTRVTNYIQWIADNI 354
PGVYT+V+++ +WI I
Sbjct: 342 PGVYTKVSDFREWIFQAI 359
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 69/251 (27%), Positives = 123/251 (49%), Gaps = 27/251 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ GQ+PW + NGK + CGG+++ +++++TAAHCV
Sbjct: 1 VVGGEDAKPGQFPWQVVL---------NGKVDAFCGGSIVNEKWIVTAAHCVETGV---- 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII----HEQYTSARKL--NDIALFRLREDAPLSD 221
V G ++E+T E +R +I H Y +A +DIAL L E L+
Sbjct: 48 -KITVVAGEHNIEETEH---TEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNS 103
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+ PIC+ D + + + +V+GWG +G + L+++++ +VD C +
Sbjct: 104 YVTPICIA-DKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATC---LRS 159
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT
Sbjct: 160 TKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYT 219
Query: 342 RVTNYIQWIAD 352
+V+ Y+ WI +
Sbjct: 220 KVSRYVNWIKE 230
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 111 bits (278), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 70/248 (28%), Positives = 123/248 (49%), Gaps = 21/248 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ GQ+PW + NGK + CGG+++ +++++TAAHCV
Sbjct: 1 VVGGEDAKPGQFPWQVVL---------NGKVDAFCGGSIVNEKWIVTAAHCVETGV---- 47
Query: 168 EPYIVHVGSIDLEDTS-SGVSIEIERPIIHEQYTSA-RKLN-DIALFRLREDAPLSDLIQ 224
V G ++E+T + + R I H Y +A K N DIAL L E L+ +
Sbjct: 48 -KITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
PIC+ D + + + +V+GWG +G + L+++++ +VD C +
Sbjct: 107 PICIA-DKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKF 162
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT+V+
Sbjct: 163 TIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVS 222
Query: 345 NYIQWIAD 352
Y+ WI +
Sbjct: 223 RYVNWIKE 230
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 111 bits (278), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 70/248 (28%), Positives = 123/248 (49%), Gaps = 21/248 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ GQ+PW + NGK + CGG+++ +++++TAAHCV
Sbjct: 1 VVGGEDAKPGQFPWQVVL---------NGKVDAFCGGSIVNEKWIVTAAHCVETGV---- 47
Query: 168 EPYIVHVGSIDLEDTS-SGVSIEIERPIIHEQYTSA-RKLN-DIALFRLREDAPLSDLIQ 224
V G ++E+T + + R I H Y +A K N DIAL L E L+ +
Sbjct: 48 -KITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVT 106
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
PIC+ D + + + +V+GWG +G + L+++++ +VD C +
Sbjct: 107 PICIA-DKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATC---LRSTKF 162
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT+V+
Sbjct: 163 TIYNNMFCAGFHEGGRDSCQGDAGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVS 222
Query: 345 NYIQWIAD 352
Y+ WI +
Sbjct: 223 RYVNWIKE 230
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 110 bits (276), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 68/251 (27%), Positives = 123/251 (49%), Gaps = 27/251 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ GQ+PW + NGK + CGG+++ +++++TAAHCV
Sbjct: 1 VVGGEDAKPGQFPWQVVL---------NGKVDAFCGGSIVNEKWIVTAAHCVETGV---- 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII----HEQYTSARKL--NDIALFRLREDAPLSD 221
V G ++E+T E +R +I H + +A +DIAL L E L+
Sbjct: 48 -KITVVAGEHNIEETEH---TEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNS 103
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+ PIC+ D + + + +V+GWG +G + L+++++ +VD C +
Sbjct: 104 YVTPICIA-DKEYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATC---LRS 159
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT
Sbjct: 160 TKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYT 219
Query: 342 RVTNYIQWIAD 352
+V+ Y+ WI +
Sbjct: 220 KVSRYVNWIKE 230
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 68/251 (27%), Positives = 123/251 (49%), Gaps = 27/251 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ GQ+PW + NGK + CGG+++ +++++TAAHCV
Sbjct: 1 VVGGEDAKPGQFPWQVVL---------NGKVDAFCGGSIVNEKWIVTAAHCVETGV---- 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII----HEQYTSARKL--NDIALFRLREDAPLSD 221
V G ++E+T E +R +I H + +A +DIAL L E L+
Sbjct: 48 -KITVVAGEHNIEETEH---TEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNS 103
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+ PIC+ D + + + +V+GWG +G + L+++++ +VD C +
Sbjct: 104 YVTPICIA-DKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATC---LRS 159
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
TI N+ CAG P + ++ ++ G++S+G++CA G G+YT
Sbjct: 160 TKFTITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYT 219
Query: 342 RVTNYIQWIAD 352
+V+ Y+ WI +
Sbjct: 220 KVSRYVNWIKE 230
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 110 bits (274), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 77/246 (31%), Positives = 111/246 (45%), Gaps = 14/246 (5%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG +G+ PW + NG +CGG LI +V++AAHC D +
Sbjct: 1 IVGGKDCPKGECPWQVLL-------LVNGAQ--LCGGTLINTIWVVSAAHCF--DKIKNW 49
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
I +G DL E S + + II Y +DIAL RL + L+D + P+
Sbjct: 50 RNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPL 109
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT- 285
CLP T L + V+GWG + RG + L+ + + + C Q G +
Sbjct: 110 CLPERTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSP 169
Query: 286 -INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
I E + CAG P +Y+ G+VS+G+ CA VG GVYTRV+
Sbjct: 170 NITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVS 229
Query: 345 NYIQWI 350
YI+W+
Sbjct: 230 QYIEWL 235
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 77/246 (31%), Positives = 111/246 (45%), Gaps = 14/246 (5%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG +G+ PW + NG +CGG LI +V++AAHC D +
Sbjct: 1 IVGGKVCPKGECPWQVLL-------LVNGAQ--LCGGTLINTIWVVSAAHCF--DKIKNW 49
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
I +G DL E S + + II Y +DIAL RL + L+D + P+
Sbjct: 50 RNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPL 109
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT- 285
CLP T L + V+GWG + RG + +L + + + C Q G +
Sbjct: 110 CLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSP 169
Query: 286 -INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
I E + CAG P +Y+ G+VS+G+ CA VG GVYTRV+
Sbjct: 170 NITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVS 229
Query: 345 NYIQWI 350
YI+W+
Sbjct: 230 QYIEWL 235
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 25/257 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+WPW ++ R +G +CGG+L++ +VLTAAHC P+
Sbjct: 1 IVGGRDTSLGRWPWQVSL-------RYDGAH--LCGGSLLSGDWVLTAAHCF-PERNRVL 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY------TSARKLNDIALFRLREDAPLSD 221
+ V G++ + + G+ + ++ + H Y S NDIAL L PL++
Sbjct: 51 SRWRVFAGAV-AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTE 109
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
IQP+CLP L + K V GWG+T + G + L+ ++ ++ N C
Sbjct: 110 YIQPVCLPAAGQ---ALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGA-DF 165
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLM----YPLDTKYYIIGVVSYGKKCAEVGFP 337
YG I + CAG P + ++ + G+VS+G CA P
Sbjct: 166 YGNQIKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKP 225
Query: 338 GVYTRVTNYIQWIADNI 354
GVYT+V+++ +WI I
Sbjct: 226 GVYTKVSDFREWIFQAI 242
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 109 bits (272), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 74/245 (30%), Positives = 112/245 (45%), Gaps = 21/245 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT E G+WPW A++ + R CG LI ++++AAHC + Y
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHR---------CGATLINATWLVSAAHCFT-----TY 46
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ S + S + + R I+HE+Y DI+L L P ++ + +C
Sbjct: 47 KNPARWTASFGVTIKPSKMKRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVC 106
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP + E FV G+G+ G LR Q++++D C + + Y I
Sbjct: 107 LP---DASYEFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQA-YNDAIT 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTK--YYIIGVVSYGKKCAEVGFPGVYTRVTN 345
+LCAG L PL+ D + +Y+ G+VS+G +CA+ PGVYTRVT
Sbjct: 163 PRMLCAGSLEGKTDACQGDSGGPLVSS-DARDIWYLAGIVSWGDECAKPNKPGVYTRVTA 221
Query: 346 YIQWI 350
WI
Sbjct: 222 LRDWI 226
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 108 bits (271), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 20/270 (7%)
Query: 97 CGVNAFNSSK-RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTA 155
CG+ + + GG ++ PW AAI + RR++G+ ++CGG LI+ +VLTA
Sbjct: 2 CGLRKYKEPQLHSTGGLFTDITSHPWQAAI--FAQNRRSSGE-RFLCGGILISSCWVLTA 58
Query: 156 AHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLRE 215
AHC + + +V + ++ + ++++ I+H+++ NDIAL +L+
Sbjct: 59 AHCFQESYLPD-QLKVVLGRTYRVKPGEEEQTFKVKKYIVHKEFDDDTYNNDIALLQLKS 117
Query: 216 DAPL----SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL-SPKLRHVQISVV 270
D+P SD ++ ICLP + NL +L + ++G+G P S +L+ + +
Sbjct: 118 DSPQCAQESDSVRAICLP-EANL--QLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLY 174
Query: 271 DNPKCRQIFSNYGATINENILCAG------VLXXXXXXXXXXXXXPLMYPLDTKYYIIGV 324
+ +C F + T+ N+LCAG + PL+ D ++G+
Sbjct: 175 PSSRCAPKFL-FNKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLLGI 233
Query: 325 VSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
+S+G C E PGVYT+VTNY+ WI DN+
Sbjct: 234 ISWGVGCGEKDVPGVYTKVTNYLGWIRDNM 263
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 108 bits (270), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 120/254 (47%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW + ++R R WM CGG+LI ++VLTAAHCV PD
Sbjct: 1 IVGGQEAPRSKWPWQ--VSLRVRDRY------WMHFCGGSLIHPQWVLTAAHCVGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ + DIAL L E +S +
Sbjct: 52 --DLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG PL P L+ V++ +++N C +
Sbjct: 110 VMLP----PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T I +++LCAG PL+ ++ + GVVS+G+ CA+
Sbjct: 166 AYTGDDVRIIRDDMLCAG--NSQRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 108 bits (270), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 120/254 (47%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW + ++R R WM CGG+LI ++VLTAAHCV PD
Sbjct: 1 IVGGQEAPRSKWPWQ--VSLRVRDRY------WMHFCGGSLIHPQWVLTAAHCVGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ + DIAL L E +S +
Sbjct: 52 --DLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG PL P L+ V++ +++N C +
Sbjct: 110 VMLP----PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T I +++LCAG PL+ ++ + GVVS+G+ CA+
Sbjct: 166 AYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 108 bits (269), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW ++ R +G P WM CGG+LI ++VLTAAHCV PD
Sbjct: 1 IVGGQEAPRSKWPWQVSL-------RVHG-PYWMHFCGGSLIHPQWVLTAAHCVGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ +A+ DIAL L E +S +
Sbjct: 52 --DLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG L P L+ V++ +++N C +
Sbjct: 110 VTLP----PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T + +++LCAG PL+ ++ + GVVS+G+ CA+
Sbjct: 166 AYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 108 bits (269), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW ++ R +G P WM CGG+LI ++VLTAAHCV PD
Sbjct: 1 IVGGQEAPRSKWPWQVSL-------RVHG-PYWMHFCGGSLIHPQWVLTAAHCVGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ +A+ DIAL L E +S +
Sbjct: 52 --DLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG L P L+ V++ +++N C +
Sbjct: 110 VTLP----PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T + +++LCAG PL+ ++ + GVVS+G+ CA+
Sbjct: 166 AYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 108 bits (269), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 81/254 (31%), Positives = 122/254 (48%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW ++ R +G P WM CGG+LI ++VLTAAHCV PD
Sbjct: 1 IVGGQEAPRSKWPWQVSL-------RVHG-PYWMHFCGGSLIHPQWVLTAAHCVGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ +A+ DIAL L E +S +
Sbjct: 52 --DLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG L P L+ V++ +++N C +
Sbjct: 110 VTLP----PASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T + +++LCAG PL+ ++ + GVVS+G+ CA+
Sbjct: 166 AYTGDDVRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 115/253 (45%), Gaps = 25/253 (9%)
Query: 108 IVGGTPSERGQWPWMAA-----IGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPD 162
IVGGT + G++P+ + IGF CG ++ + Y +TA HCV D
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFH----------FCGASIYNENYAITAGHCVYGD 50
Query: 163 TTGEYEPYIVHVGSIDLE-DTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
+ G +D+ + S I + + I+HE + NDI+L +L +D
Sbjct: 51 DYENPSGLQIVAGELDMSVNEGSEQIITVSKIILHENFDYNLLDNDISLLKLSGSLTFND 110
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
+ PI LP + + V GWG+T G L+ V + +V + CR ++
Sbjct: 111 NVAPIALPEQGHTAT-----GDVIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCR---AD 162
Query: 282 YGAT-INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVY 340
YGA I ++++CAGV PL Y+ G+VS+G CA G+PGVY
Sbjct: 163 YGADEILDSMICAGVPEGGKDSCQGDSGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVY 222
Query: 341 TRVTNYIQWIADN 353
T V+ ++ WI N
Sbjct: 223 TEVSYHVDWIKAN 235
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG+ + GQWPW +I ++ +CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVH---------VCGGSLVSEQWVLSAAHCFPSEH--HK 49
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII-HEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
E Y V +G+ L+ S + + II H Y DIAL +L S I+PI
Sbjct: 50 EAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPK-LRHVQISVVDNPKCRQIFSNYGA 284
LP ++ V GWG L+PK L+ +++ ++ C ++ N A
Sbjct: 110 SLP---AAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLY-NIDA 165
Query: 285 T------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
+ E+++CAG + PL P++ +Y+ G+VS+G C PG
Sbjct: 166 KPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPG 225
Query: 339 VYTRVTNYIQWIADNIS 355
VYT ++Y WI ++
Sbjct: 226 VYTLASSYASWIQSKVT 242
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG+ + GQWPW +I ++ +CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVH---------VCGGSLVSEQWVLSAAHCFPSEH--HK 49
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII-HEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
E Y V +G+ L+ S + + II H Y DIAL +L S I+PI
Sbjct: 50 EAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPK-LRHVQISVVDNPKCRQIFSNYGA 284
LP ++ V GWG L+PK L+ +++ ++ C ++ N A
Sbjct: 110 SLP---AAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLY-NIDA 165
Query: 285 T------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
+ E+++CAG + PL P++ +Y+ G+VS+G C PG
Sbjct: 166 KPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPG 225
Query: 339 VYTRVTNYIQWIADNIS 355
VYT ++Y WI ++
Sbjct: 226 VYTLASSYASWIQSKVT 242
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 20/270 (7%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
P +CG +I+GG + PW AAI RR G ++CGG+L++
Sbjct: 6 PEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSP 61
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL--- 205
+V++A HC + E YIV++G L + G + E+E I+H+ Y SA L
Sbjct: 62 CWVISATHCFI--DYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHH 118
Query: 206 NDIALFRLRED----APLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP- 260
NDIAL ++R A S IQ ICLP ++ ++ + + G+G L P
Sbjct: 119 NDIALLKIRSKEGRCAQPSRTIQTICLP---SMYNDPQFGTSCEITGFGKENSTDYLYPE 175
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
+L+ + ++ + +C+Q YG+ + +LCA PL+ L +
Sbjct: 176 QLKMTVVKLISHRECQQPH-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT 234
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
+ G+VS+G+ CA PGVYTRV++++ WI
Sbjct: 235 LTGIVSWGRGCALKDKPGVYTRVSHFLPWI 264
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 105 bits (261), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 72/257 (28%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG+ + GQWPW +I ++ +CGG+L+++++VL+AAHC +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVH---------VCGGSLVSEQWVLSAAHCFPSEH--HK 49
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII-HEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
E Y V +G+ L+ S + + II H Y DIAL +L S I+PI
Sbjct: 50 EAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPI 109
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPK-LRHVQISVVDNPKCRQIFSNYGA 284
LP + V GWG L+PK L+ +++ ++ C ++ N A
Sbjct: 110 SLP---AANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALY-NIDA 165
Query: 285 T------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
+ E+++CAG + PL P++ +Y+ G+VS+G C PG
Sbjct: 166 KPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPG 225
Query: 339 VYTRVTNYIQWIADNIS 355
VYT ++Y WI ++
Sbjct: 226 VYTLASSYASWIQSKVT 242
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 105 bits (261), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 79/254 (31%), Positives = 119/254 (46%), Gaps = 28/254 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWM--CGGALITKRYVLTAAHCVSPDTTG 165
IVGG + R +WPW + ++R R WM CGG+LI ++VLTAAHC+ PD
Sbjct: 1 IVGGQEAPRSKWPWQ--VSLRVRDRY------WMHFCGGSLIHPQWVLTAAHCLGPDVK- 51
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ + V + + + R I+H Q+ + DIAL L E +S +
Sbjct: 52 --DLATLRVQLREQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEEPVNISSRVHT 109
Query: 226 ICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCRQIFSNY 282
+ LP SE F P +V GWG PL P L+ V++ +++N C +
Sbjct: 110 VMLP----PASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLG 165
Query: 283 GAT------INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGF 336
T I +++LCAG PL+ ++ + GVVS+ + CA+
Sbjct: 166 AYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCKVNGTWLQAGVVSWDEGCAQPNR 223
Query: 337 PGVYTRVTNYIQWI 350
PG+YTRVT Y+ WI
Sbjct: 224 PGIYTRVTYYLDWI 237
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 105 bits (261), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 28/265 (10%)
Query: 97 CGVNA----FNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYV 152
CGV A + RIV G + G WPW ++ K CGG+LI + +V
Sbjct: 1 CGVPAIQPVLSGLSRIVNGEEAVPGSWPWQVSLQDKTGFH--------FCGGSLINENWV 52
Query: 153 LTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDIALF 211
+TAAHC G +V G D +S + ++I + + +Y S NDI L
Sbjct: 53 VTAAHC------GVTTSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLL 106
Query: 212 RLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVV 270
+L A S + +CLP ++ + T GWG T + +P +L+ + ++
Sbjct: 107 KLSTAASFSQTVSAVCLPSASD---DFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLL 163
Query: 271 DNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK 330
N C++ +G I + ++CAG PL+ + + ++G+VS+G
Sbjct: 164 SNTNCKKY---WGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSS 218
Query: 331 CAEVGFPGVYTRVTNYIQWIADNIS 355
PGVY RVT + W+ ++
Sbjct: 219 TCSTSTPGVYARVTALVNWVQQTLA 243
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 104 bits (259), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 74/252 (29%), Positives = 116/252 (46%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++ G+WPW ++ A G+ +CG +LI+ ++++AAHC D Y
Sbjct: 1 VVGGTDADEGEWPWQVSL-------HALGQGH-ICGASLISPNWLVSAAHCYIDDRGFRY 52
Query: 168 EPYIVHVGSIDLEDTSS----GVSIE-IERPIIHEQYTSARKLNDIALFRLREDAPLSDL 222
+ L D S GV ++R I H + DIAL L + A S +
Sbjct: 53 SDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM 112
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNY 282
++PICLP +++ K +V GWG T + G + L+ +I V++ C +
Sbjct: 113 VRPICLPDASHV---FPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQ- 168
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLM-YPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
I ++C G L PL D + + GVVS+G CA+ PGVYT
Sbjct: 169 --QITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYT 226
Query: 342 RVTNYIQWIADN 353
R+ + WI +N
Sbjct: 227 RLPLFRDWIKEN 238
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 104 bits (259), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 19/253 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG + WPW ++ + ++G+ CGG L+ + +VLTAAHC+S T
Sbjct: 1 VVGGEDARPNSWPWQVSLQYD-----SSGQWRHTCGGTLVDQSWVLTAAHCISSSRT--- 52
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSAR--KLNDIALFRLREDAPLSDLIQ 224
Y V +G L G +++++ + ++H+ + S + NDIAL +L L+D IQ
Sbjct: 53 --YRVVLGRHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQ 110
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
CLP + L +V GWG G L+ Q+ VVD C + +G+
Sbjct: 111 LGCLPAAGTI---LPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKP-GWWGS 166
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK--CAEVGFPGVYTR 342
T+ N++CAG + ++ + G+VS+G C P V+TR
Sbjct: 167 TVKTNMICAGGDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTR 226
Query: 343 VTNYIQWIADNIS 355
V+NYI WI I+
Sbjct: 227 VSNYIDWINSVIA 239
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++ G+WPW ++ A G+ +CG +LI+ ++++AAHC D Y
Sbjct: 1 VVGGTDADEGEWPWQVSL-------HALGQGH-ICGASLISPNWLVSAAHCYIDDRGFRY 52
Query: 168 EPYIVHVGSIDLEDTSS----GVSIE-IERPIIHEQYTSARKLNDIALFRLREDAPLSDL 222
+ L D S GV ++R I H + DIAL L + A S +
Sbjct: 53 SDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM 112
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNY 282
++PICLP +++ K +V GWG T + G + L+ +I V+ C +
Sbjct: 113 VRPICLPDASHV---FPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQ- 168
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLM-YPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
I ++C G L PL D + + GVVS+G CA+ PGVYT
Sbjct: 169 --QITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYT 226
Query: 342 RVTNYIQWIADN 353
R+ + WI +N
Sbjct: 227 RLPLFRDWIKEN 238
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 82/277 (29%), Positives = 137/277 (49%), Gaps = 34/277 (12%)
Query: 97 CGVNAFNSSK-RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTA 155
CG+ ++ + RI GG ++ PW AAI K RR+ G+ ++CGG LI+ ++L+A
Sbjct: 2 CGLRQYSQPQFRIKGGLFADIASHPWQAAIFAK--HRRSPGE-RFLCGGILISSCWILSA 58
Query: 156 AHCVSPDTTGEYEPYIVHVGSIDLEDTSSGV------SIEIERPIIHEQYTSARKLNDIA 209
AHC E + H ++ L T V E+E+ I+H+++ NDIA
Sbjct: 59 AHCFQ-------ERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIA 111
Query: 210 LFRLRED----APLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL-SPKLRH 264
L +L+ D A S +++ +CLP +L +L + ++G+G P S +L+
Sbjct: 112 LLQLKSDSSRCAQESSVVRTVCLP-PADL--QLPDWTECELSGYGKHEALSPFYSERLKE 168
Query: 265 VQISVVDNPKC-RQIFSNYGATINENILCAGVL------XXXXXXXXXXXXXPLMYPLDT 317
+ + + +C Q N T+ +N+LCAG PL+ D
Sbjct: 169 AHVRLYPSSRCTSQHLLN--RTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDG 226
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
+ ++G++S+G C + PGVYT+VTNY+ WI DN+
Sbjct: 227 RMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 263
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 103 bits (257), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 76/257 (29%), Positives = 114/257 (44%), Gaps = 17/257 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG +E G WPWM ++ + N + CGG L+ +VLTAAHC +
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYH---NNRRYHTCGGILLNSHWVLTAAHCF--KNKKKV 55
Query: 168 EPYIVHVGSIDLEDTSSGVSIE------IERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
+ + G+ ++ S+ +E IIHE+Y S ++NDIAL ++ P
Sbjct: 56 TDWRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGP 115
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP-LSPKLRHVQISVVDNPKCRQIFS 280
I P CLP +T +V GWG +GP SP L+ +++++D C
Sbjct: 116 FIGPGCLPQFK--AGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNST-R 172
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMY--PLDTKYYIIGVVSYGKKCAEVGFPG 338
Y I +CAG PLM + + ++G+ S+G CA PG
Sbjct: 173 WYNGRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPG 232
Query: 339 VYTRVTNYIQWIADNIS 355
VYT Y+ WIA I
Sbjct: 233 VYTSTWPYLNWIASKIG 249
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 96 ECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTA 155
+CG +I+GG + PW AAI RR G ++CGG+LI+ +V++A
Sbjct: 4 QCGQKTLRPRFKIIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISA 59
Query: 156 AHCVSPDTTGEYEPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALF 211
HC + E YIV++G L + G + E+E I+H+ Y SA L NDIAL
Sbjct: 60 THCFI--DYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALL 116
Query: 212 RLRED----APLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQ 266
++R A S IQ I LP ++ ++ + + G+G L P +L+
Sbjct: 117 KIRSKEGRCAQPSRTIQTISLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTV 173
Query: 267 ISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVS 326
+ ++ + +C+Q YG+ + +LCA PL+ L + + G+VS
Sbjct: 174 VKLISHRECQQPH-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVS 232
Query: 327 YGKKCAEVGFPGVYTRVTNYIQWI 350
+G+ CA PGVYTRV++++ WI
Sbjct: 233 WGRGCALKDKPGVYTRVSHFLPWI 256
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 79/256 (30%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 106 KRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTG 165
KRIVGG ++ G PW AI + A+G CGG I ++LTAAHC+ T
Sbjct: 320 KRIVGGKRAQLGDLPWQVAI------KDASGI---TCGGIYIGGCWILTAAHCLRASKTH 370
Query: 166 EYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
Y+ + V I D V ++R I HE Y + NDIAL +++D D P
Sbjct: 371 RYQIWTTVVDWIH-PDLKRIVIEYVDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELP 429
Query: 226 ICLPYDTNLRSELFE-RKTPFVAGWG-----STVFRGPLSPKLRHVQISVVDNPKCRQIF 279
+P LF+ T V+GWG VF L+ ++ ++ N C + +
Sbjct: 430 RSIPACVPWSPYLFQPNDTCIVSGWGREKDNERVF------SLQWGEVKLISN--CSKFY 481
Query: 280 SNYGATINENILCAGVLXXXXXXXXXXXXXPLM-YPLDTKYYIIGVVSYGKKCAEVGFPG 338
N + + CAG PL+ + Y+ GVVS+G+ C + FPG
Sbjct: 482 GN--RFYEKEMECAGTYDGSIDACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPG 539
Query: 339 VYTRVTNYIQWIADNI 354
VYT+V NY WI+ ++
Sbjct: 540 VYTKVANYFDWISYHV 555
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 18/251 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYT--SARKLNDIALFRLRED----APLS 220
E YIV++G L + G + E+E I+H+ Y+ + NDIAL ++R A S
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPS 114
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIF 279
IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 115 RTIQTICLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPH 171
Query: 280 SNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGV 339
YG+ + +LCA PL+ L + + G+VS+G+ CA PGV
Sbjct: 172 Y-YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGV 230
Query: 340 YTRVTNYIQWI 350
YTRV++++ WI
Sbjct: 231 YTRVSHFLPWI 241
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 102 bits (254), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 65/250 (26%), Positives = 110/250 (44%), Gaps = 24/250 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IV G + G WPW ++ K CGG+LI + +V+TAAHC G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFH--------FCGGSLINENWVVTAAHC------GVT 46
Query: 168 EPYIVHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+V G D +S + ++I + + +Y S NDI L +L A S + +
Sbjct: 47 TSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAV 106
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGAT 285
CLP ++ + T GWG T + +P +L+ + ++ N C++ +G
Sbjct: 107 CLPSASD---DFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKY---WGTK 160
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
I + ++CAG PL+ + + ++G+VS+G PGVY RVT
Sbjct: 161 IKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTA 218
Query: 346 YIQWIADNIS 355
+ W+ ++
Sbjct: 219 LVNWVQQTLA 228
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 101 bits (252), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 101 bits (252), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 101 bits (251), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 126/252 (50%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ ICLP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTICLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 HY-YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 101 bits (251), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 27/250 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G+ PW A + N + E CGG ++++ Y+LTAAHC+ +
Sbjct: 1 IVGGYNCKDGEVPWQALL--------INEENEGFCGGTILSEFYILTAAHCLY-----QA 47
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ + V VG + E G ++ E+E I H ++T DIA+ RL+ + P
Sbjct: 48 KRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPA 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGAT 285
LP + ++GWG+T G P +L+ + V+ KC ++Y
Sbjct: 108 SLP-----TAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCE---ASYPGK 159
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
I N+ C G L P++ + GVVS+G CA+ PGVYT+V N
Sbjct: 160 ITSNMFCVGFLEGGKDSCQGDSGGPVV----CNGQLQGVVSWGDGCAQKNKPGVYTKVYN 215
Query: 346 YIQWIADNIS 355
Y++WI + I+
Sbjct: 216 YVKWIKNTIA 225
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 73/252 (28%), Positives = 115/252 (45%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++ G+WPW ++ A G+ +CG +LI+ ++++AAHC D Y
Sbjct: 1 VVGGTDADEGEWPWQVSL-------HALGQGH-ICGASLISPNWLVSAAHCYIDDRGFRY 52
Query: 168 EPYIVHVGSIDLEDTSS----GVSIE-IERPIIHEQYTSARKLNDIALFRLREDAPLSDL 222
+ L D S GV ++R I H + DIAL L + A S +
Sbjct: 53 SDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSM 112
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNY 282
++PI LP +++ K +V GWG T + G + L+ +I V++ C +
Sbjct: 113 VRPISLPDASHV---FPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQ- 168
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLM-YPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
I ++C G L PL D + + GVVS+G CA+ PGVYT
Sbjct: 169 --QITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYT 226
Query: 342 RVTNYIQWIADN 353
R+ + WI +N
Sbjct: 227 RLPLFRDWIKEN 238
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 26/264 (9%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
PS D + V R+VGG + WPW ++ + CGG LI+
Sbjct: 544 PSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISP 595
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDI 208
+VLTAAHC+ + + Y V +G+ + V IE+ R + RK DI
Sbjct: 596 EWVLTAAHCL--EKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLE----PTRK--DI 647
Query: 209 ALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRHVQ 266
AL +L A ++D + P CLP + + +R F+ GWG T F L L+ Q
Sbjct: 648 ALLKLSSPAVITDKVIPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKEAQ 701
Query: 267 ISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVS 326
+ V++N C + + + LCAG L PL+ KY + GV S
Sbjct: 702 LPVIENKVCNR-YEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTS 760
Query: 327 YGKKCAEVGFPGVYTRVTNYIQWI 350
+G CA PGVY RV+ ++ WI
Sbjct: 761 WGLGCARPNKPGVYVRVSRFVTWI 784
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 21/268 (7%)
Query: 97 CGV-NAFNSSKRIVGGT-PSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CG+ N +I G T +E G++PWM A+ K +G+ + +CGG+LI VLT
Sbjct: 118 CGIRNERGLDFKITGQTNEAEYGEFPWMVAV-LKANVIPGSGEEQLVCGGSLIAPSVVLT 176
Query: 155 AAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIE---IERPIIHEQYTSARKLNDIALF 211
AHCV+ + + + G D + + I + IIH + +ND+AL
Sbjct: 177 GAHCVNSYQS-NLDAIKIRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALL 235
Query: 212 RLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVF--RGPLSPKLRHVQISV 269
L +D I ICLP +S++F+ F +GWG F R S L+ +Q+
Sbjct: 236 LLDRPLVQADNIGTICLPQ----QSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPT 291
Query: 270 VDNPKCRQIFSN----YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD---TKYYII 322
VD KC+ N +++ +CAG PL P ++Y +
Sbjct: 292 VDRDKCQADLRNTRLGLKFVLDQTFVCAGG-EQGKDTCTGDGGSPLFCPDPRNPSRYMQM 350
Query: 323 GVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
G+V++G C + PGVY V ++ WI
Sbjct: 351 GIVAWGIGCGDENVPGVYANVAHFRNWI 378
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 85/269 (31%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 97 CGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAA 156
CG++A + RI GG ++ G +PW I G GAL+ +VLTAA
Sbjct: 76 CGLSARTTGGRIYGGQKAKPGDFPWQVLI--------LGGT---TAAGALLYDNWVLTAA 124
Query: 157 HCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLRE 215
H V + + + +G++ + E IHE YT NDIAL +L
Sbjct: 125 HAVY-EQKHDASALDIRMGTLK-RLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNN 182
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNP 273
++ I PICLP +E F R +GWG T RG L+ L +V I +VD+
Sbjct: 183 KVVINSNITPICLP---RKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQ 238
Query: 274 KCRQIFSNY---GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT---KYYIIGVVSY 327
KC + ++ N+LCAG+ L++ LD+ ++++ G+VS+
Sbjct: 239 KCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSW 297
Query: 328 GK-KCAEVGFPGVYTRVTNYIQWIADNIS 355
G C E G GVYT+V NYI WI + IS
Sbjct: 298 GSMNCGEAGQYGVYTKVINYIPWIENIIS 326
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 76/249 (30%), Positives = 114/249 (45%), Gaps = 30/249 (12%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
R+VGG + WPW ++ + + CGG LI+ +VLTAAHC+ + +
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQH--------FCGGTLISPEWVLTAAHCL--EKSPR 65
Query: 167 YEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLI 223
Y V +G+ ++LE IE+ R + RK DIAL +L A ++D +
Sbjct: 66 PSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK--DIALLKLSSPAVITDKV 117
Query: 224 QPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
P CLP + + +R F+ GWG T F L L+ Q+ V++N C + +
Sbjct: 118 IPACLPSPNYM---VADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNR-YEF 170
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
+ LCAG L PL+ KY + GV S+G CA PGVY
Sbjct: 171 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYV 230
Query: 342 RVTNYIQWI 350
RV+ ++ WI
Sbjct: 231 RVSRFVTWI 239
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
PS D + V R+VGG + WPW ++ + CGG LI+
Sbjct: 3 PSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISP 54
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN 206
+VLTAAHC+ + + Y V +G+ ++LE IE+ R + RK
Sbjct: 55 EWVLTAAHCL--EKSPRPSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK-- 104
Query: 207 DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRH 264
DIAL +L A ++D + P CLP + + +R F+ GWG T F L L+
Sbjct: 105 DIALLKLSSPAVITDKVIPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKE 158
Query: 265 VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGV 324
Q+ V++N C + + + LCAG L PL+ KY + GV
Sbjct: 159 AQLPVIENKVCNR-YEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGV 217
Query: 325 VSYGKKCAEVGFPGVYTRVTNYIQWI 350
S+G CA PGVY RV+ ++ WI
Sbjct: 218 TSWGLGCARPNKPGVYVRVSRFVTWI 243
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
PS D + V R+VGG + WPW ++ + CGG LI+
Sbjct: 3 PSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISP 54
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN 206
+VLTAAHC+ + + Y V +G+ ++LE IE+ R + RK
Sbjct: 55 EWVLTAAHCL--EKSPRPSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK-- 104
Query: 207 DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRH 264
DIAL +L A ++D + P CLP + + +R F+ GWG T F L L+
Sbjct: 105 DIALLKLSSPAVITDKVIPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKE 158
Query: 265 VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGV 324
Q+ V++N C + + + LCAG L PL+ KY + GV
Sbjct: 159 AQLPVIENKVCNR-YEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGV 217
Query: 325 VSYGKKCAEVGFPGVYTRVTNYIQWI 350
S+G CA PGVY RV+ ++ WI
Sbjct: 218 TSWGLGCARPNKPGVYVRVSRFVTWI 243
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
PS D + V R+VGG + WPW ++ + CGG LI+
Sbjct: 1 PSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISP 52
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN 206
+VLTAAHC+ + + Y V +G+ ++LE IE+ R + RK
Sbjct: 53 EWVLTAAHCL--EKSPRPSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK-- 102
Query: 207 DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRH 264
DIAL +L A ++D + P CLP + + +R F+ GWG T F L L+
Sbjct: 103 DIALLKLSSPAVITDKVIPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKE 156
Query: 265 VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGV 324
Q+ V++N C + + + LCAG L PL+ KY + GV
Sbjct: 157 AQLPVIENKVCNR-YEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGV 215
Query: 325 VSYGKKCAEVGFPGVYTRVTNYIQWI 350
S+G CA PGVY RV+ ++ WI
Sbjct: 216 TSWGLGCARPNKPGVYVRVSRFVTWI 241
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 99.8 bits (247), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 30/266 (11%)
Query: 90 PSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITK 149
PS D + V R+VGG + WPW ++ + CGG LI+
Sbjct: 2 PSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISP 53
Query: 150 RYVLTAAHCVSPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN 206
+VLTAAHC+ + + Y V +G+ ++LE IE+ R + RK
Sbjct: 54 EWVLTAAHCL--EKSPRPSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK-- 103
Query: 207 DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRH 264
DIAL +L A ++D + P CLP + + +R F+ GWG T F L L+
Sbjct: 104 DIALLKLSSPAVITDKVIPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKE 157
Query: 265 VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGV 324
Q+ V++N C + + + LCAG L PL+ KY + GV
Sbjct: 158 AQLPVIENKVCNR-YEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGV 216
Query: 325 VSYGKKCAEVGFPGVYTRVTNYIQWI 350
S+G CA PGVY RV+ ++ WI
Sbjct: 217 TSWGLGCARPNKPGVYVRVSRFVTWI 242
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 99.4 bits (246), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTIALP---SMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 99.4 bits (246), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTIALP---SMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 99.4 bits (246), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTIALP---SMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 33/265 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG ++ PW AAI K RR+ G+ ++CGG LI+ ++L+AAHC
Sbjct: 1 IKGGLFADIASHPWQAAIFAK--HRRSPGE-RFLCGGILISSCWILSAAHCFQ------- 50
Query: 168 EPYIVHVGSIDLEDTSSGV------SIEIERPIIHEQYTSARKLNDIALFRLRED----A 217
E + H ++ L T V E+E+ I+H+++ NDIAL +L+ D A
Sbjct: 51 ERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCA 110
Query: 218 PLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL-SPKLRHVQISVVDNPKC- 275
S +++ +CLP +L +L + ++G+G P S +L+ + + + +C
Sbjct: 111 QESSVVRTVCLP-PADL--QLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCT 167
Query: 276 RQIFSNYGATINENILCAGVL------XXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK 329
Q N T+ +N+LCAG PL+ D + ++G++S+G
Sbjct: 168 SQHLLN--RTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGL 225
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNI 354
C + PGVYT+VTNY+ WI DN+
Sbjct: 226 GCGQKDVPGVYTKVTNYLDWIRDNM 250
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTISLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 99.0 bits (245), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 17/256 (6%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + G WPWM ++ N + +CGG+L+ +++LTAAHC +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYH---NNRRYHVCGGSLLNSQWLLTAAHCFR--IKKKV 55
Query: 168 EPYIVHVGSIDLE-DTSSGVSIE-----IERPIIHEQYTSARKLNDIALFRLREDAPLSD 221
+ + G+ ++E T+ V +E+ IIHE+Y+++ + NDIAL ++
Sbjct: 56 TDWRLIFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGH 115
Query: 222 LIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP-LSPKLRHVQISVVDNPKCRQIFS 280
I P CLP + +T +VAGWG SP L+ ++ ++D C
Sbjct: 116 FIGPGCLPQFRAGPPRV--PQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNST-R 172
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMY--PLDTKYYIIGVVSYGKKCAEVGFPG 338
Y I +CAG PLM + Y ++G+ S+G CA PG
Sbjct: 173 WYNGRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPG 232
Query: 339 VYTRVTNYIQWIADNI 354
VYT +Y+ WIA I
Sbjct: 233 VYTSTWSYLNWIASKI 248
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 76/249 (30%), Positives = 113/249 (45%), Gaps = 30/249 (12%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
R+VGG + WPW ++ + CGG LI+ +VLTAAHC+ + +
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISPEWVLTAAHCL--EKSPR 66
Query: 167 YEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLI 223
Y V +G+ ++LE IE+ R + RK DIAL +L A ++D +
Sbjct: 67 PSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK--DIALLKLSSPAVITDKV 118
Query: 224 QPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
P CLP + + +R F+ GWG T F L L+ Q+ V++N C + +
Sbjct: 119 IPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNR-YEF 171
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
+ LCAG L PL+ KY + GV S+G CA PGVY
Sbjct: 172 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYV 231
Query: 342 RVTNYIQWI 350
RV+ ++ WI
Sbjct: 232 RVSRFVTWI 240
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTIALP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+LI+ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLISPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTISLP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 HY-YGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 76/249 (30%), Positives = 113/249 (45%), Gaps = 30/249 (12%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
R+VGG + WPW ++ + CGG LI+ +VLTAAHC+ + +
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMH--------FCGGTLISPEWVLTAAHCL--EKSPR 66
Query: 167 YEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLI 223
Y V +G+ ++LE IE+ R + RK DIAL +L A ++D +
Sbjct: 67 PSSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK--DIALLKLSSPAVITDKV 118
Query: 224 QPICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRHVQISVVDNPKCRQIFSN 281
P CLP + + +R F+ GWG T F L L+ Q+ V++N C + +
Sbjct: 119 IPACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNR-YEF 171
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
+ LCAG L PL+ KY + GV S+G CA PGVY
Sbjct: 172 LNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYV 231
Query: 342 RVTNYIQWI 350
RV+ ++ WI
Sbjct: 232 RVSRFVTWI 240
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 98.2 bits (243), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 84/269 (31%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 97 CGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAA 156
CG++A + +I GG ++ G +PW I G GAL+ +VLTAA
Sbjct: 151 CGLSARTTGGQIYGGQKAKPGDFPWQVLI--------LGGT---TAAGALLYDNWVLTAA 199
Query: 157 HCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLRE 215
H V + + + +G++ + E IHE YT NDIAL +L
Sbjct: 200 HAVY-EQKHDASALDIRMGTLK-RLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNN 257
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNP 273
++ I PICLP +E F R +GWG T RG L+ L +V I +VD+
Sbjct: 258 KVVINSNITPICLP---RKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQ 313
Query: 274 KCRQIFSNYG---ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT---KYYIIGVVSY 327
KC + ++ N+LCAG+ L++ LD+ ++++ G+VS+
Sbjct: 314 KCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSW 372
Query: 328 GK-KCAEVGFPGVYTRVTNYIQWIADNIS 355
G C E G GVYT+V NYI WI + IS
Sbjct: 373 GSMNCGEAGQYGVYTKVINYIPWIENIIS 401
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 97.8 bits (242), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 77/252 (30%), Positives = 125/252 (49%), Gaps = 20/252 (7%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG + PW AAI RR G ++CGG+L++ +V++A HC +
Sbjct: 1 IIGGEFTTIENQPWFAAI----YRRHRGGSVTYVCGGSLMSPCWVISATHCFI--DYPKK 54
Query: 168 EPYIVHVGSIDLEDTSSG-VSIEIERPIIHEQYTSARKL---NDIALFRLRED----APL 219
E YIV++G L + G + E+E I+H+ Y SA L NDIAL ++R A
Sbjct: 55 EDYIVYLGRSRLNSNTQGEMKFEVENLILHKDY-SADTLAHHNDIALLKIRSKEGRCAQP 113
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQI 278
S IQ I LP ++ ++ + + G+G L P +L+ + ++ + +C+Q
Sbjct: 114 SRTIQTIALP---SMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQP 170
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPG 338
YG+ + +LCA PL+ L + + G+VS+G+ CA PG
Sbjct: 171 H-YYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPG 229
Query: 339 VYTRVTNYIQWI 350
VYTRV++++ WI
Sbjct: 230 VYTRVSHFLPWI 241
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 97.8 bits (242), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 80/273 (29%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 91 SPDNNECGVNAFNSS---KRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALI 147
SP CG + RI+GG+ S G PW+AAI + C G+L+
Sbjct: 16 SPGRQACGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAIYIG----------DSFCAGSLV 65
Query: 148 TKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN- 206
+V++AAHC S + ++ + T + IE+ I + Y+ +
Sbjct: 66 HTCWVVSAAHCFSHSPPRDSVSVVLGQHFFN-RTTDVTQTFGIEKYIPYTLYSVFNPSDH 124
Query: 207 DIALFRLRED----APLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPK 261
D+ L RL++ A S +QPICLP + + + +AGWG S
Sbjct: 125 DLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKCQ---IAGWGHLDENVSGYSSS 181
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI 321
LR + +V + KC YGA I+ N+LCAG PL + Y+
Sbjct: 182 LREALVPLVADHKCSSP-EVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYL 240
Query: 322 IGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
G++S+G C + PGVYTRV NY+ WI D I
Sbjct: 241 YGIISWGDGCGRLHKPGVYTRVANYVDWINDRI 273
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 72/249 (28%), Positives = 110/249 (44%), Gaps = 23/249 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG ++ WPW ++ +K + CGG+LI + +V+TAAHCV T
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYH-----TCGGSLIRQGWVMTAAHCVDSART--- 52
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLN--DIALFRLREDAPLSDLIQ 224
+ V +G +L I + IH + S DIAL RL A L+ +Q
Sbjct: 53 --WRVVLGEHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQ 110
Query: 225 PICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG 283
LP +++ P ++ GWG T GPLS L+ + VD+ C +G
Sbjct: 111 LAALP----PSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSS-SGWWG 165
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSY--GKKCAEVGFPGVYT 341
+T+ ++CAG PL ++ YY+ GV S+ C P V+T
Sbjct: 166 STVKTTMVCAG--GGANSGCNGDSGGPLNCQVNGSYYVHGVTSFVSSSGCNASKKPTVFT 223
Query: 342 RVTNYIQWI 350
RV+ YI W+
Sbjct: 224 RVSAYISWM 232
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 31/249 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+ G P RG PW A+ +G + CGG L+ +R+VLTAAHC +
Sbjct: 1 IIDGAPCARGSHPWQVAL--------LSGN-QLHCGGVLVNERWVLTAAHC-------KM 44
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
Y VH+GS L D + I+ + H Y++ +ND+ L +L A LS +++ +
Sbjct: 45 NEYTVHLGSDTLGDRRA-QRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVR 103
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATI 286
LP R E T V+GWG+T P L V + ++ C +++ + +
Sbjct: 104 LPS----RCEP-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL---L 155
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTN 345
++LCAG+ PL+ + + G+VS+G C + PGVYT+V
Sbjct: 156 ENSMLCAGIPDSKKNACNGDSGGPLV----CRGTLQGLVSWGTFPCGQPNDPGVYTQVCK 211
Query: 346 YIQWIADNI 354
+ +WI D +
Sbjct: 212 FTKWINDTM 220
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 72/249 (28%), Positives = 116/249 (46%), Gaps = 31/249 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+ G P RG PW A+ +G + CGG L+ +R+VLTAAHC +
Sbjct: 1 IIDGAPCARGSHPWQVAL--------LSGN-QLHCGGVLVNERWVLTAAHC-------KM 44
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
Y VH+GS L D + I+ + H Y++ +ND+ L +L A LS +++ +
Sbjct: 45 NEYTVHLGSDTLGDRRA-QRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVR 103
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATI 286
LP R E T V+GWG+T P L V + ++ C +++ + +
Sbjct: 104 LPS----RCEP-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDL---L 155
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTN 345
++LCAG+ PL+ + + G+VS+G C + PGVYT+V
Sbjct: 156 ENSMLCAGIPDSKKNACNGDSGGPLV----CRGTLQGLVSWGTFPCGQPNDPGVYTQVCK 211
Query: 346 YIQWIADNI 354
+ +WI D +
Sbjct: 212 FTKWINDTM 220
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E+G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCILYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ +H +Y L+ DIAL +L++ P S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNVEKISM-LEKIYVHPRYNWRENLDRDIALLKLKKPVPFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP + S L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ ++ I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---ASTRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRKGKYGFYTHVFRLKRWIQKVID 255
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 75/253 (29%), Positives = 113/253 (44%), Gaps = 21/253 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG+ S G PW+AAI + C G+L+ +V++AAHC S +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIG----------DSFCAGSLVHTCWVVSAAHCFSHSPPRDS 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLRED----APLSDL 222
++ + T + IE+ I + Y+ + D+ L RL++ A S
Sbjct: 51 VSVVLGQHFFN-RTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQF 109
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPKLRHVQISVVDNPKCRQIFSN 281
+QPICLP + + + +AGWG S LR + +V + KC
Sbjct: 110 VQPICLPEPGSTFPAGHKCQ---IAGWGHLDENVSGYSSSLREALVPLVADHKCSSP-EV 165
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
YGA I+ N+LCAG PL + Y+ G++S+G C + PGVYT
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYT 225
Query: 342 RVTNYIQWIADNI 354
RV NY+ WI D I
Sbjct: 226 RVANYVDWINDRI 238
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 75/253 (29%), Positives = 113/253 (44%), Gaps = 21/253 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG+ S G PW+AAI + C G+L+ +V++AAHC S +
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIG----------DSFCAGSLVHTCWVVSAAHCFSHSPPRDS 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLRED----APLSDL 222
++ + T + IE+ I + Y+ + D+ L RL++ A S
Sbjct: 51 VSVVLGQHFFN-RTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQF 109
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFR-GPLSPKLRHVQISVVDNPKCRQIFSN 281
+QPICLP + + + +AGWG S LR + +V + KC
Sbjct: 110 VQPICLPEPGSTFPAGHKCQ---IAGWGHLDENVSGYSSSLREALVPLVADHKCSSP-EV 165
Query: 282 YGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
YGA I+ N+LCAG PL + Y+ G++S+G C + PGVYT
Sbjct: 166 YGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYT 225
Query: 342 RVTNYIQWIADNI 354
RV NY+ WI D I
Sbjct: 226 RVANYVDWINDRI 238
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 94.4 bits (233), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 117/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E+G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCILYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ +H +Y L+ DIAL +L++ P S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNVEKISM-LEKIYVHPRYNWRENLDRDIALLKLKKPVPFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP + S L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ ++ I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---ASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V WI I
Sbjct: 230 GCDRKGKYGFYTHVFRLKAWIQKVID 255
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 30/248 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG + WPW ++ + CGG LI+ +VLTAAHC+ + +
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMH--------FCGGTLISPEWVLTAAHCL--EKSPRP 67
Query: 168 EPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQ 224
Y V +G+ ++LE IE+ R + RK DIAL +L A ++D +
Sbjct: 68 SSYKVILGAHQEVNLEPHVQ--EIEVSRLFLE----PTRK--DIALLKLSSPAVITDKVI 119
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGST--VFRGPLSPKLRHVQISVVDNPKCRQIFSNY 282
P CLP + + +R F+ GWG T F L L Q+ V++N C + +
Sbjct: 120 PACLPSPNYV---VADRTECFITGWGETQGTFGAGL---LMEAQLPVIENKVCNR-YEFL 172
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTR 342
+ LCAG L PL+ KY + GV S+G CA PGVY R
Sbjct: 173 NGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVR 232
Query: 343 VTNYIQWI 350
V+ ++ WI
Sbjct: 233 VSRFVTWI 240
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 32/271 (11%)
Query: 97 CGVNAFNSS--KRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CG+ F+ +I G P+++G PW+A + NG+P CGG+L+ +++T
Sbjct: 143 CGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLS------HLNGQP--FCGGSLLGSSWIVT 194
Query: 155 AAHCV------------SPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSA 202
AAHC+ D + I+ L + + ++ +H QY
Sbjct: 195 AAHCLHQSLDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPN 254
Query: 203 RKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKL 262
ND+AL L E L+ + PICLP + V+GWG F L
Sbjct: 255 TFENDVALVELLESPVLNAFVMPICLPEGPQQEGAMV-----IVSGWGKQ-FLQRFPETL 308
Query: 263 RHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT---KY 319
++I +VD+ C++ ++ + +++CAG P M L+ ++
Sbjct: 309 MEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGP-MVTLNRERGQW 367
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
Y++G VS+G C + GVY+ + + WI
Sbjct: 368 YLVGTVSWGDDCGKKDRYGVYSYIHHNKDWI 398
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y RK NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNKRRKNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 75/260 (28%), Positives = 117/260 (45%), Gaps = 26/260 (10%)
Query: 105 SKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTT 164
S R+V G + W W ++ ++ +G CGG+LI +V+TA HC+S T
Sbjct: 9 SSRVVNGEDAVPYSWSWQVSLQYE-----KDGAFHHTCGGSLIAPDWVVTAGHCISTSRT 63
Query: 165 GEYEPYIVHVGSID---LEDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPL 219
Y V +G D L+ + + I +H + S NDIAL +L A L
Sbjct: 64 -----YQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQL 118
Query: 220 SDLIQPICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQI 278
D +Q LP ++ + P +++GWG GPL KL+ + VVD C Q
Sbjct: 119 GDKVQLANLP----PAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQ- 173
Query: 279 FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYP-LDTKYYIIGVVSY--GKKCAEVG 335
+ +G T+ + ++CAG PL P D + + GV S+ C +
Sbjct: 174 YDWWGITVKKTMVCAG--GDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIK 231
Query: 336 FPGVYTRVTNYIQWIADNIS 355
P V+TRV+ +I WI + I+
Sbjct: 232 KPTVFTRVSAFIDWINETIA 251
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 75/244 (30%), Positives = 110/244 (45%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + FK +GK +CGG L+ + +VLTAAHC+
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFK-----TSGKSH-ICGGFLVREDFVLTAAHCLGSSIN--- 51
Query: 168 EPYIVHVGSID-LEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ + +E + I + RPI H Y NDI L +L A ++D + PI
Sbjct: 52 ----VTLGAHNIMERERTQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDKVSPI 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP +E+ VAGWG P + KL+ V + V KC F NY I
Sbjct: 108 NLPRSL---AEVKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARFKNY---I 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+CAG PL+ G+VSYG+ P VYTR++++
Sbjct: 162 PFTQICAGDPSKRKNSFSGDSGGPLV----CNGVAQGIVSYGRNDGTT--PDVYTRISSF 215
Query: 347 IQWI 350
+ WI
Sbjct: 216 LSWI 219
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/266 (29%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G PG YT V +WI I
Sbjct: 230 GCDRDGKPGFYTHVFRLKKWIQKVID 255
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E+G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCILYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ +H +Y L+ DIAL +L++ P S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNVEKISM-LEKIYVHPRYNWRENLDRDIALLKLKKPVPFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP + S L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ ++ I +N+ CAG + P + ++Y +G+VS G
Sbjct: 173 CK---ASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGA 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRKGKYGFYTHVFRLKRWIQKVID 255
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 76/260 (29%), Positives = 115/260 (44%), Gaps = 24/260 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
D I P+CLP S L V GWG+ +G S L+ V + +V+ P C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKEKGQPSV-LQVVNLPIVERPVCK---D 168
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGKKCAEVG 335
+ I +N+ CAG + P + ++Y +G+VS+G+ C G
Sbjct: 169 STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 228
Query: 336 FPGVYTRVTNYIQWIADNIS 355
G YT V +WI I
Sbjct: 229 KYGFYTHVFRLKKWIQKVID 248
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 22/254 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++R WP ++ ++ A+ CGG LI + +V+TAAHCV + T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAH-----TCGGTLIRQNWVMTAAHCVDRELT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPLSDLIQ 224
+ V VG +L ++ + + +++ ++H + + DIAL RL + L+ +Q
Sbjct: 53 --FRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 225 PICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG 283
LP + +P ++ GWG T G L+ L+ + VD C S +G
Sbjct: 111 LGVLPR----AGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS-SSYWG 165
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK--CAEVGFPGVYT 341
+T+ +++CAG PL ++ +Y + GV S+ + C P V+T
Sbjct: 166 STVKNSMVCAGG-DGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFT 224
Query: 342 RVTNYIQWIADNIS 355
RV+ YI WI + I+
Sbjct: 225 RVSAYISWINNVIA 238
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 10 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 62
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 63 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 121
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 122 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 181
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 182 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGG 238
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 239 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 286
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 11 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 63
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 64 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 122
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 123 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 182
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 183 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 239
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 240 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 287
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 78/267 (29%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDT 163
RIV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDK 217
Query: 164 TGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPL 219
+V +G E +S+ +E+ IH +Y L+ DIAL +L++
Sbjct: 218 NFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAF 276
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNP 273
SD I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 277 SDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERP 336
Query: 274 KCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYG 328
C+ + I +N+ CAG + P + ++Y +G+VS+G
Sbjct: 337 VCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWG 393
Query: 329 KKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ C G G YT V +WI I
Sbjct: 394 EGCDRDGKYGFYTHVFRLKKWIQKVID 420
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 22/254 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++R WP ++ ++ A+ CGG LI + +V+TAAHCV + T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAH-----TCGGTLIRQNWVMTAAHCVDRELT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPLSDLIQ 224
+ V VG +L ++ + + +++ ++H + + DIAL RL + L+ +Q
Sbjct: 53 --FRVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 225 PICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG 283
LP + +P ++ GWG T G L+ L+ + VD C S +G
Sbjct: 111 LGVLPR----AGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS-SSYWG 165
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK--CAEVGFPGVYT 341
+T+ +++CAG PL ++ +Y + GV S+ + C P V+T
Sbjct: 166 STVKNSMVCAGG-DGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFT 224
Query: 342 RVTNYIQWIADNIS 355
RV+ YI WI + I+
Sbjct: 225 RVSAYISWINNVIA 238
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 9 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 61
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 120
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 237
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 238 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 11 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 63
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 64 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 122
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 123 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 182
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 183 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 239
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 240 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 287
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 9 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 61
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYEANIEKISM-LEKIYIHPRY 120
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 237
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 238 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 78/267 (29%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDT 163
RIV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDK 101
Query: 164 TGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPL 219
+V +G E +S+ +E+ IH +Y L+ DIAL +L++
Sbjct: 102 NFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAF 160
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNP 273
SD I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 161 SDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERP 220
Query: 274 KCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYG 328
C+ + I +N+ CAG + P + ++Y +G+VS+G
Sbjct: 221 VCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWG 277
Query: 329 KKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ C G G YT V +WI I
Sbjct: 278 EGCDRDGKYGFYTHVFRLKKWIQKVID 304
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 9 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 61
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 120
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 237
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 238 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 8 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 60
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 61 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 119
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 120 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 179
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 180 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 236
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 237 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 284
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 78/266 (29%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
CA G G YT V +WI I
Sbjct: 230 GCARKGKYGFYTHVFRLKKWIQKVID 255
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 9 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 61
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 62 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 120
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 121 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 180
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 181 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 237
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 238 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 285
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 15 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 67
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 68 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 126
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 127 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 186
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 187 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 243
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 244 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 291
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 82/288 (28%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G+ +E G PW + K E +CG +
Sbjct: 15 FEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGAS 67
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D +V +G E +S+ +E+ IH +Y
Sbjct: 68 LISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRY 126
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L++ SD I P+CLP S L V GWG+ T
Sbjct: 127 NWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTA 186
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
G P L+ V + +V+ P C+ + I +N+ CAG
Sbjct: 187 NVGKGQPSVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGG 243
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 244 PFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 291
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 78/267 (29%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDT 163
RIV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDK 53
Query: 164 TGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPL 219
+V +G E +S+ +E+ IH +Y L+ DIAL +L++
Sbjct: 54 NFTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAF 112
Query: 220 SDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNP 273
SD I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 SDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERP 172
Query: 274 KCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYG 328
C+ + I +N+ CAG + P + ++Y +G+VS+G
Sbjct: 173 VCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWG 229
Query: 329 KKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ C G G YT V +WI I
Sbjct: 230 EGCDRDGKYGFYTHVFRLKKWIQKVID 256
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 70/254 (27%), Positives = 121/254 (47%), Gaps = 22/254 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT ++R WP ++ ++ A+ CGG LI + +V+TAAHCV + T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAH-----TCGGTLIRQNWVMTAAHCVDRELT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPLSDLIQ 224
+ V VG +L ++ + + +++ ++H + + DIAL RL + L+ +Q
Sbjct: 53 --FRVVVGEHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQ 110
Query: 225 PICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG 283
LP + +P ++ GWG T G L+ L+ + VD C S +G
Sbjct: 111 LGVLPR----AGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSS-SSYWG 165
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK--CAEVGFPGVYT 341
+T+ +++CAG PL ++ +Y + GV S+ + C P V+T
Sbjct: 166 STVKNSMVCAGG-DGVRSGCQGDSGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFT 224
Query: 342 RVTNYIQWIADNIS 355
RV+ YI WI + I+
Sbjct: 225 RVSAYISWINNVIA 238
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 81/258 (31%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG ++ G +PW I G GAL+ +VLTAAH V + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--------LGGT---TAAGALLYDNWVLTAAHAVY-EQKHDA 48
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLREDAPLSDLIQPI 226
+ +G++ + E IHE YT NDIAL +L ++ I PI
Sbjct: 49 SALDIRMGTLK-RLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPI 107
Query: 227 CLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNY-- 282
CLP +E F R +GWG T RG L+ L +V I +VD+ KC +
Sbjct: 108 CLP---RKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQKCTAAYEKPPY 163
Query: 283 -GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT---KYYIIGVVSYGK-KCAEVGFP 337
++ N+LCAG+ L++ LD+ ++++ G+VS+G C E G
Sbjct: 164 PRGSVTANMLCAGLESGGKDSCRGDSGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQY 222
Query: 338 GVYTRVTNYIQWIADNIS 355
GVYT+V NYI WI + IS
Sbjct: 223 GVYTKVINYIPWIENIIS 240
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 81/258 (31%), Positives = 118/258 (45%), Gaps = 28/258 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I GG ++ G +PW I G GAL+ +VLTAAH V + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--------LGGT---TAAGALLYDNWVLTAAHAVY-EQKHDA 48
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLREDAPLSDLIQPI 226
+ +G++ + E IHE YT NDIAL +L ++ I PI
Sbjct: 49 SALDIRMGTLK-RLSPHYTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPI 107
Query: 227 CLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNY-- 282
CLP +E F R +GWG T RG L+ L +V I +VD+ KC +
Sbjct: 108 CLP---RKEAESFMRTDDIGTASGWGLTQ-RGFLARNLMYVDIPIVDHQKCTAAYEKPPY 163
Query: 283 -GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT---KYYIIGVVSYGK-KCAEVGFP 337
++ N+LCAG+ L++ LD+ ++++ G+VS+G C E G
Sbjct: 164 PRGSVTANMLCAGLESGGKDSCRGDAGGALVF-LDSETERWFVGGIVSWGSMNCGEAGQY 222
Query: 338 GVYTRVTNYIQWIADNIS 355
GVYT+V NYI WI + IS
Sbjct: 223 GVYTKVINYIPWIENIIS 240
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 76/260 (29%), Positives = 114/260 (43%), Gaps = 24/260 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTAYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
D I P+CLP S L V GWG+ G S L+ V + +V+ P C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSV-LQVVNLPIVERPVCK---D 168
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGKKCAEVG 335
+ I +N+ CAG + P + ++Y +G+VS+G+ C G
Sbjct: 169 STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 228
Query: 336 FPGVYTRVTNYIQWIADNIS 355
G YT V +WI I
Sbjct: 229 KYGFYTHVFRLKKWIQKVID 248
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 91.3 bits (225), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 76/260 (29%), Positives = 114/260 (43%), Gaps = 24/260 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
D I P+CLP S L V GWG+ G S L+ V + +V+ P C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSV-LQVVNLPIVERPVCK---D 168
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGKKCAEVG 335
+ I +N+ CAG + P + ++Y +G+VS+G+ C G
Sbjct: 169 STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 228
Query: 336 FPGVYTRVTNYIQWIADNIS 355
G YT V +WI I
Sbjct: 229 KYGFYTHVFRLKKWIQKVID 248
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRKGKYGFYTHVFRLKKWIQKVID 255
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVS-IEIERPIIHEQY 199
CGG+LI ++V++AAHC V +G ++ I + I+H Y
Sbjct: 24 FCGGSLINSQWVVSAAHCXKSGIQ-------VRLGEDNINVVEGNEQFISASKSIVHPSY 76
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 77 NSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTSX 131
Query: 260 PK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P L+ ++ ++ + C+ S Y I N+ CAG L P++ +
Sbjct: 132 PDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGXLEGGKDSCQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 30/258 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV-------- 159
I G P+++G PW+A + NG+P CGG+L+ +++TAAHC+
Sbjct: 1 IFNGRPAQKGTTPWIAML------SHLNGQP--FCGGSLLGSSWIVTAAHCLHQSLDPKD 52
Query: 160 ----SPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLRE 215
D + I+ L + + ++ +H QY ND+AL L E
Sbjct: 53 PTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVELLE 112
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKC 275
L+ + PICLP + V+GWG F L ++I +VD+ C
Sbjct: 113 SPVLNAFVMPICLPEGPQQEGAMV-----IVSGWGKQ-FLQRFPETLMEIEIPIVDHSTC 166
Query: 276 RQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD---TKYYIIGVVSYGKKCA 332
++ ++ + +++CAG P M L+ ++Y++G VS+G C
Sbjct: 167 QKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGP-MVTLNRERGQWYLVGTVSWGDDCG 225
Query: 333 EVGFPGVYTRVTNYIQWI 350
+ GVY+ + + WI
Sbjct: 226 KKDRYGVYSYIHHNKDWI 243
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 78/266 (29%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+GK
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGK 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 23/260 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
D I P+CLP S L V GWG+ L+ V + +V+ P C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCK---D 169
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGKKCAEVG 335
+ I +N+ CAG + P + ++Y +G+VS+G+ C G
Sbjct: 170 STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 229
Query: 336 FPGVYTRVTNYIQWIADNIS 355
G YT V +WI I
Sbjct: 230 KYGFYTHVFRLKKWIQKVID 249
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 72/237 (30%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT + G +P++ +I NG P W CGG+L+ VLTAAHCVS +
Sbjct: 1 IVGGTSASAGDFPFIVSI-------SRNGGP-W-CGGSLLNANTVLTAAHCVSGYAQSGF 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ + GS L TS G++ + +H Y+ ND+A+ +L P I
Sbjct: 52 Q---IRAGS--LSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYAR 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATI 286
L S+ + VAGWG+T G +P L V + +V CR + + I
Sbjct: 105 LAAS---GSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGT--SAI 159
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRV 343
+ CAGV P+ +D+ +IG VS+G CA + GVY V
Sbjct: 160 TNQMFCAGVSSGGKDSCQGDSGGPI---VDSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 30 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 81
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 82 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 136
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 137 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 193
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 194 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 227
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 29 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 80
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 81 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 135
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 136 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 192
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 193 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 226
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 80/288 (27%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 86 FTKLPSPDNNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGA 145
F K D E + RIV G +E G PW + K E +CG +
Sbjct: 28 FEKKQVQDQTEKELFESYIEGRIVEGQDAEVGLSPWQVMLFRK-------SPQELLCGAS 80
Query: 146 LITKRYVLTAAHCV---SPDTTGEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQY 199
LI+ R+VLTAAHC+ D + +V +G E +S+ +++ IH +Y
Sbjct: 81 LISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISM-LDKIYIHPRY 139
Query: 200 TSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TV 253
L+ DIAL +L+ LSD I P+CLP L V GWG+ T
Sbjct: 140 NWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTT 199
Query: 254 FRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-- 310
+ P L+ V + +V+ P C+ ++ I +N+ CAG
Sbjct: 200 SVAEVQPSVLQVVNLPLVERPVCK---ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGG 256
Query: 311 ---LMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ P + ++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 257 PFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 304
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 76/260 (29%), Positives = 115/260 (44%), Gaps = 26/260 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFS 280
D I P+CLP S L V GWG+ +G S L+ V + +V+ P C+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGN--LKGQPSV-LQVVNLPIVERPVCK---D 166
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGKKCAEVG 335
+ I +N+ CAG + P + ++Y +G+VS+G+ C G
Sbjct: 167 STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDG 226
Query: 336 FPGVYTRVTNYIQWIADNIS 355
G YT V +WI I
Sbjct: 227 KYGFYTHVFRLKKWIQKVID 246
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 73/237 (30%), Positives = 106/237 (44%), Gaps = 25/237 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGGT + G +P++ +I NG P W CGG+L+ VLTAAHCVS +
Sbjct: 1 IVGGTSASAGDFPFIVSI-------SRNGGP-W-CGGSLLNANTVLTAAHCVSGYAQSGF 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ + GS L TS G++ + +H Y+ ND+A+ +L P I
Sbjct: 52 Q---IRAGS--LSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYAR 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATI 286
L S+ + VAGWG+T G +P L V + +V CR + + I
Sbjct: 105 LAAS---GSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGT--SAI 159
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRV 343
+ CAGV P+ +D+ +IG VS+G CA + GVY V
Sbjct: 160 TNQMFCAGVSSGGKDSCQGDXGGPI---VDSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C + G G YT V +WI I
Sbjct: 230 GCRDDGKYGFYTHVFRLKKWIQKVID 255
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDXGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 78/266 (29%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K RR+ G+ ++CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAK--HRRSPGE-RFLCGASLISDRWVLTAAHCLLYPPWDKN 57
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 58 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 116
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 117 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 176
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CA + P + ++Y +G+VS+G+
Sbjct: 177 CK---DSTRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 233
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 234 GCDRDGKYGFYTHVFRLKKWIQKVID 259
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 75/249 (30%), Positives = 106/249 (42%), Gaps = 31/249 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+V G P ++ P+ AA+ +CGG LI +VLTAAHC P+
Sbjct: 1 LVHGGPCDKTSHPYQAAL---------YTSGHLLCGGVLIHPLWVLTAAHCKKPNLQ--- 48
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G +L + SS + R +IH Y +A DI L RL A LS+LIQP+
Sbjct: 49 ----VFLGKHNLRQRESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 104
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
L D + + + + GWG T G ++ I +V +C Y I
Sbjct: 105 PLERDCSANT-----TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHA---YPGQI 155
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTN 345
+N+LCAG PL+ ++ G+VS+G C PGVYT V
Sbjct: 156 TQNMLCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVSWGNIPCGSKEKPGVYTNVCR 211
Query: 346 YIQWIADNI 354
Y WI I
Sbjct: 212 YTNWIQKTI 220
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLXSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + + LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASVSLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCAGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 38 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 89
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 90 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 144
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 145 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 201
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 202 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 235
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSTSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG S P+MA + + +CGG LI++++VLTAAHC + T
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGL-----RVICGGFLISRQFVLTAAHCKGREIT--- 52
Query: 168 EPYIVHVGSIDLED-TSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ D+ S+ I++E+ IIHE Y S L+DI L +L + L+ + +
Sbjct: 53 ----VILGAHDVRKRESTQQKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNVV 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP ++ + + AGWG T R P S LR V++ ++D C +Y
Sbjct: 109 PLPSPSDF---IHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKAC----VDYRYYE 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+ +C G PL+ G+VSYG A+ P ++TRV+ Y
Sbjct: 162 YKFQVCVGSPTTLRAAFMGDSGGPLLCAGVAH----GIVSYGHPDAKP--PAIFTRVSTY 215
Query: 347 IQWI 350
+ WI
Sbjct: 216 VPWI 219
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKIGFYTHVFRLKKWIQKVID 255
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKFGFYTHVFRLKKWIQKVID 255
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 44 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 95
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 96 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 150
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 151 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDAGGPVVCSGKL 207
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 208 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 241
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 44 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 95
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 96 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 150
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 151 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 207
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 208 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 241
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYEANIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 78/266 (29%), Positives = 116/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXX---XXXXPLMY--PLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG P + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYEANIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLIDSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L + I LP S ++GWG+T G
Sbjct: 76 YDSNTLNNDIMLIKLKSAASLDSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 74/246 (30%), Positives = 110/246 (44%), Gaps = 24/246 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M R N + E CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLINEENEGFCGGALYAQDIVLTAAHCVSG--SGNN 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + +T D AL +L QPI
Sbjct: 51 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGFTKETYGKDWALIKLA---------QPIN 100
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR S++ N
Sbjct: 101 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVAN 159
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDT--KYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
E ++CAG M+ D ++ +G+VS+G CA G+PGVYT V+
Sbjct: 160 E-MICAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVST 218
Query: 346 YIQWIA 351
+ IA
Sbjct: 219 FASAIA 224
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 26/246 (10%)
Query: 119 WPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSID 178
W W ++ ++ +G CGG+LI +V+TA HC+S T Y V +G D
Sbjct: 10 WSWQVSLQYE-----KDGAFHHTCGGSLIAPDWVVTAGHCISTSRT-----YQVVLGEYD 59
Query: 179 ---LEDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPLSDLIQPICLPYDTN 233
LE + + I +H + S NDIAL +L A L D +Q LP
Sbjct: 60 RSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANLP---- 115
Query: 234 LRSELFERKTP-FVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATINENILC 292
++ + P +++GWG GPL KL+ + VD C Q + +G T+ + ++C
Sbjct: 116 PAGDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQ-WDWWGITVKKTMVC 174
Query: 293 AGVLXXXXXXXXXXXXXPLMYP-LDTKYYIIGVVSY--GKKCAEVGFPGVYTRVTNYIQW 349
AG PL P D + + GV S+ C + P V+TRV+ +I W
Sbjct: 175 AG--GDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDW 232
Query: 350 IADNIS 355
I + I+
Sbjct: 233 IDETIA 238
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 71/236 (30%), Positives = 104/236 (44%), Gaps = 25/236 (10%)
Query: 109 VGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYE 168
VGGT + G +P++ +I NG P W CGG+L+ VLTAAHCVS ++
Sbjct: 2 VGGTSASAGDFPFIVSI-------SRNGGP-W-CGGSLLNANTVLTAAHCVSGYAQSGFQ 52
Query: 169 PYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPICL 228
+ GS L TS G++ + +H Y+ ND+A+ +L P I L
Sbjct: 53 ---IRAGS--LSRTSGGITSSLSSVRVHPSYSGNN--NDLAILKLSTSIPSGGNIGYARL 105
Query: 229 PYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATIN 287
S+ + VAGWG+T G +P L V + +V CR + + I
Sbjct: 106 AAS---GSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGT--SAIT 160
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRV 343
+ CAGV P+ +D+ +IG VS+G CA + GVY V
Sbjct: 161 NQMFCAGVSSGGKDSCQGDSGGPI---VDSSNTLIGAVSWGNGCARPNYSGVYASV 213
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FIENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 114/266 (42%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/258 (26%), Positives = 123/258 (47%), Gaps = 32/258 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + ++PW ++ RR+ ++ CGG++I R+V+ AAHC+ GE
Sbjct: 1 IVGGIEARPYEFPWQVSV----RRKSSDSH---FCGGSIINDRWVVCAAHCMQ----GEA 49
Query: 168 EPYIVHVGSIDLEDTSSGVSI----EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLI 223
+ V + D+S+ ++ +++ ++E Y A ND+++ + +
Sbjct: 50 PALVSLV--VGEHDSSAASTVRQTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINV 107
Query: 224 QPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNY 282
PIC P N + RK+ +GWG+ G P LR+V +++ N C ++++
Sbjct: 108 GPICAPDPAN---DYVYRKSQ-CSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTS- 162
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK-----YYIIGVVSYGKKCAEVGFP 337
TI ++++CA PL K + ++G+VS+G CA G+P
Sbjct: 163 -DTIYDDMICA--TDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCAS-GYP 218
Query: 338 GVYTRVTNYIQWIADNIS 355
GVY+RV + WI D I+
Sbjct: 219 GVYSRVGFHAGWITDTIT 236
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 87.8 bits (216), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDL-IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
Y S NDI L +L+ A L D + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLXDSRVASISLP-----TSCASAGTQCLISGWGNTKSSGT 130
Query: 258 LSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L+ ++ ++ + C+ S Y I N+ CAG L P++
Sbjct: 131 SYPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK 187
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 LQ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 222
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 74/250 (29%), Positives = 106/250 (42%), Gaps = 31/250 (12%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
++V G P ++ P+ AA+ +CGG LI +VLTAAHC P+
Sbjct: 1 KLVHGGPCDKTSHPYQAAL---------YTSGHLLCGGVLIHPLWVLTAAHCKKPNLQ-- 49
Query: 167 YEPYIVHVGSIDLEDTSSGVSIE-IERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
V +G +L S + R +IH Y +A DI L RL A LS+LIQP
Sbjct: 50 -----VFLGKHNLRQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP 104
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT 285
+ L D + ++ + + GWG T G ++ I +V +C Y
Sbjct: 105 LPLERDCSAQT-----TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHA---YPGQ 155
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVT 344
I +N+LCAG PL+ ++ G+VS+G C PGVYT V
Sbjct: 156 ITQNMLCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVSWGNIPCGSKEKPGVYTNVC 211
Query: 345 NYIQWIADNI 354
Y WI I
Sbjct: 212 RYTNWIQKTI 221
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 41/277 (14%)
Query: 97 CGV--NAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CGV F +RI+GG+ ++ +PW W GGALI + +VLT
Sbjct: 70 CGVPREPFEEKQRIIGGSDADIKNFPWQVFF-----------DNPW-AGGALINEYWVLT 117
Query: 155 AAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVS--IEIERPIIHEQYT-------SARKL 205
AAH V G EP ++VGS ++ + S + E IH +
Sbjct: 118 AAHVVE----GNREP-TMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFD 172
Query: 206 NDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHV 265
NDIAL RL++ + + PICLP T+ L + ++GWG T R + +L+
Sbjct: 173 NDIALVRLKDPVKMGPTVSPICLP-GTSSDYNLMDGDLGLISGWGRTEKRD-RAVRLKAA 230
Query: 266 QISVVDNPKCRQIFSNYGATINE------NILCAGVLXXXXX-XXXXXXXXPLMYPLD-T 317
++ V KC+++ E N++CAG + P D T
Sbjct: 231 RLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKT 290
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
K+Y G+VS+G +C G G+YTRV NY+ WI +
Sbjct: 291 KFYAAGLVSWGPQC---GTYGLYTRVKNYVDWIMKTM 324
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 71/253 (28%), Positives = 112/253 (44%), Gaps = 39/253 (15%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + G++P+ ++ R CG +++ VLTAAHCV D
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHR---------CGASILDNNNVLTAAHCV--DGLSNL 49
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
VHVG+ L + SG ++E ++++ Y ND+AL L +DL+QPI
Sbjct: 50 NRLKVHVGTNYL--SESGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQPIK 107
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCR----QIFSNYG 283
L + E E + GWGST G L+ +++ V +C ++ ++
Sbjct: 108 LSTN----DEDLESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQWRVIDSHI 163
Query: 284 ATINE--NILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYT 341
T+ + C G PL IG+VS+G CA +G P VYT
Sbjct: 164 CTLTKRGEGACHG---------------DSGGPLVANGAQIGIVSFGSPCA-LGEPDVYT 207
Query: 342 RVTNYIQWIADNI 354
RV++++ WI N+
Sbjct: 208 RVSSFVSWINANL 220
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ +IAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRNIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 72/245 (29%), Positives = 109/245 (44%), Gaps = 23/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M R N + E CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMV--------RLINEENEGFCGGALYAQDIVLTAAHCVSG--SGNN 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + +T D AL + L QPI
Sbjct: 51 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGFTKETYGKDWALIK---------LAQPIN 100
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR S++ N
Sbjct: 101 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSS-SSFILVAN 159
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI-IGVVSYGKKCAEVGFPGVYTRVTNY 346
E ++CAG P+ + ++ +G+VS+G+ CA G GVYT V+ +
Sbjct: 160 E-MICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 218
Query: 347 IQWIA 351
IA
Sbjct: 219 ASAIA 223
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 113/266 (42%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS G
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGA 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 75/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+ +V +G E +S+ +++ IH +Y L+ DIAL +L+ LS
Sbjct: 54 FTVDDLLVRIGKHSRTRYERKVEKISM-LDKIYIHPRYNWKENLDRDIALLKLKRPIELS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ ++ I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 113/266 (42%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS G
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGA 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 75/266 (28%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+ +V +G E +S+ +++ IH +Y L+ DIAL +L+ LS
Sbjct: 54 FTVDDLLVRIGKHSRTRYERKVEKISM-LDKIYIHPRYNWKENLDRDIALLKLKRPIELS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP L V GWG+ T + P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ ++ I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
C G G YT V +WI I
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L+ + + LP RS ++GWG+T G
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 129
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ N C+ S+Y I N++C G L P++
Sbjct: 130 SYPSLLQCLKAPVLSNSSCK---SSYPGQITGNMICVGFLQGGKDSCQGDSGGPVV---- 182
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 183 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 221
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 114/266 (42%), Gaps = 29/266 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS-----TVFRGPLSPK-LRHVQISVVDNPK 274
D I P+CLP S L V GWG+ T G P L+ V + +V+ P
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPV 172
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLDTKYYIIGVVSYGK 329
C+ + I +N+ CAG + P + ++Y +G+VS+G+
Sbjct: 173 CK---DSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGE 229
Query: 330 KCAEVGFPGVYTRVTNYIQWIADNIS 355
G G YT V +WI I
Sbjct: 230 GADRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 76/249 (30%), Positives = 109/249 (43%), Gaps = 31/249 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+V G P ++ P+ AA+ +G +CGG LI +VLTAAHC P+
Sbjct: 1 LVHGGPCDKTSHPYQAAL-------YTSG--HLLCGGVLIHPLWVLTAAHCKKPNLQ--- 48
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G +L + SS + R +IH Y +A DI L RL A LS+LIQP+
Sbjct: 49 ----VFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPL 104
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
L D + ++ + + GWG T G ++ I +V +C Y I
Sbjct: 105 PLERDCSAQT-----TSCHILGWGKTA-DGDFPDTIQCAYIHLVSREECEHA---YPGQI 155
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTN 345
+N+LCAG PL+ ++ G+VS+G C PGVYT V
Sbjct: 156 TQNMLCAGDEKYGKDSCQGDSGGPLV----CGDHLRGLVSWGNIPCGSKEKPGVYTNVCR 211
Query: 346 YIQWIADNI 354
Y WI I
Sbjct: 212 YTNWIQKTI 220
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L+ + + LP RS ++GWG+T G
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 129
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ + C+ S+Y I N++C G L P++
Sbjct: 130 SYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV---- 182
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 183 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 221
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 32 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 82
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L+ + + LP RS ++GWG+T G
Sbjct: 83 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 137
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ + C+ S+Y I N++C G L P++
Sbjct: 138 SYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV---- 190
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 191 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 229
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L+ + + LP RS ++GWG+T G
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 129
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ + C+ S+Y I N++C G L P++
Sbjct: 130 SYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV---- 182
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 183 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 221
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 77/278 (27%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 97 CG--VNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CG VN +RI+GG ++ G +PW R GGAL+ R++LT
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR-----------GGGALLGDRWILT 125
Query: 155 AAHCVSPDTTGEYEPYI-----VHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN--- 206
AAH + P E+E V +G ++E+ + I R +H Y N
Sbjct: 126 AAHTLYPK---EHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEG 182
Query: 207 DIALFRLREDAPLSDLIQPICLP-----YDTNLRSELFERKTPFVAGWGSTVFRGPLSPK 261
DIAL L L + PICLP YD L +V+G+G V ++
Sbjct: 183 DIALLELENSVTLGPNLLPICLPDNDTFYDLGLMG--------YVSGFG--VMEEKIAHD 232
Query: 262 LRHVQISVVDNPKCRQIF--SNYGATINENILCAG--VLXXXXXXXXXXXXXPLMYPLDT 317
LR V++ V + C N ++N+ CAG L + P
Sbjct: 233 LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTD 292
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++ G+VS+G C+ G+ G YT+V NY+ WI +
Sbjct: 293 RWVATGIVSWGIGCSR-GY-GFYTKVLNYVDWIKKEME 328
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 77/278 (27%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 97 CG--VNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CG VN +RI+GG ++ G +PW R GGAL+ R++LT
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR-----------GGGALLGDRWILT 125
Query: 155 AAHCVSPDTTGEYEPYI-----VHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN--- 206
AAH + P E+E V +G ++E+ + I R +H Y N
Sbjct: 126 AAHTLYPK---EHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEG 182
Query: 207 DIALFRLREDAPLSDLIQPICLP-----YDTNLRSELFERKTPFVAGWGSTVFRGPLSPK 261
DIAL L L + PICLP YD L +V+G+G V ++
Sbjct: 183 DIALLELENSVTLGPNLLPICLPDNDTFYDLGLMG--------YVSGFG--VMEEKIAHD 232
Query: 262 LRHVQISVVDNPKCRQIF--SNYGATINENILCAG--VLXXXXXXXXXXXXXPLMYPLDT 317
LR V++ V + C N ++N+ CAG L + P
Sbjct: 233 LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTD 292
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++ G+VS+G C+ G+ G YT+V NY+ WI +
Sbjct: 293 RWVATGIVSWGIGCSR-GY-GFYTKVLNYVDWIKKEME 328
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDT-SSGVSIEIERPIIHEQ 198
CGG+L+ + +V++AAHC Y+ + V +G +++ T S I R I H
Sbjct: 24 FCGGSLVNENWVVSAAHC--------YKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPN 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 76 YSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCT-----VSGWGNTMSSTAD 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
S KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 131 SDKLQCLNIPILSYSDCND---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ 187
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ----GVVSWGYGCAEPGNPGVYAKVCIFSDWLTSTMA 220
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M + CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG-------------CGGALYAQDIVLTAAHCVSG--SGNN 45
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + Y K D AL +L QPI
Sbjct: 46 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGYNGTGK--DWALIKL---------AQPIN 93
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR + N N
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVAN 152
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDT--KYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
E I CAG M+ D ++ +G+VS+G CA G+PGVYT V+
Sbjct: 153 EEI-CAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVST 211
Query: 346 YIQWIA 351
+ IA
Sbjct: 212 FASAIA 217
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDT-SSGVSIEIERPIIHEQY 199
CGG+L+ + +V++AAHC V +G +++ T S I R I H Y
Sbjct: 24 FCGGSLVNENWVVSAAHCYKSRVE-------VRLGEHNIKVTEGSEQFISSSRVIRHPNY 76
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+S NDI L +L + A L+ +QP+ LP + V+GWG+T+ S
Sbjct: 77 SSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCT-----VSGWGNTMSSTADS 131
Query: 260 PKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 132 NKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ- 187
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ---GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDT-SSGVSIEIERPIIHEQ 198
CGG+L+ + +V++AAHC Y+ + V +G +++ T S I R I H
Sbjct: 24 FCGGSLVNENWVVSAAHC--------YKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPN 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 76 YSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCT-----VSGWGNTMSSTAD 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
S KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 131 SNKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ 187
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ----GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L + + LP RS ++GWG+T G
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLXSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 129
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ + C+ S+Y I N++C G L P++
Sbjct: 130 SYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV---- 182
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 183 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 221
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP 257
+ NDI L +L A L+ + + LP RS ++GWG+T G
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNTKSSGS 129
Query: 258 LSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLD 316
P L ++ V+ + C+ S Y I N++C G L P++
Sbjct: 130 SYPSLLQCLKAPVLSDSSCK---SAYPGQITGNMICVGFLEGGKDSCQGDSGGPVV---- 182
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 183 CNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 221
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 33/251 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E P+ ++ CGG+LI +++V++A HC Y
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYH----------FCGGSLINEQWVVSAGHC--------Y 42
Query: 168 EPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ I V +G ++E I + I H QY NDI L +L A ++ +
Sbjct: 43 KSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVST 102
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGA 284
I LP + ++GWG+T G P +L+ + V+ KC ++Y
Sbjct: 103 ISLP-----TAPPATGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCE---ASYPG 154
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
I N+ C G L P++ + GVVS+G CA+ PGVYT+V
Sbjct: 155 KITSNMFCVGFLEGGKDSCQGDSGGPVV----CNGQLQGVVSWGDGCAQKNKPGVYTKVY 210
Query: 345 NYIQWIADNIS 355
NY++WI + I+
Sbjct: 211 NYVKWIKNTIA 221
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDT-SSGVSIEIERPIIHEQ 198
CGG+L+ + +V++AAHC Y+ + V +G +++ T S I R I H
Sbjct: 39 FCGGSLVNENWVVSAAHC--------YKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPN 90
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 91 YSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCT-----VSGWGNTMSSTAD 145
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
S KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 146 SNKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ 202
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 203 ----GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 235
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 70/248 (28%), Positives = 113/248 (45%), Gaps = 24/248 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + +I + K CGG LI + +VLTAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYL--QIMDEYSGSKK---CGGFLIREDFVLTAAHCSGSKIQ--- 52
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++++ I + + I H Y S NDI L +L+ A S ++P+
Sbjct: 53 ----VTLGAHNIKEQEKMQQIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVKPL 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP N++ + + +VAGWG G S L+ V+++V ++ KC NY
Sbjct: 109 NLP-RRNVKVKPGD--VCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDKA 165
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
NE +CAG PL+ K G+VSYG+ P +T+V+ +
Sbjct: 166 NE--ICAGDPKIKRASFRGDSGGPLV----CKKVAAGIVSYGQNDGST--PRAFTKVSTF 217
Query: 347 IQWIADNI 354
+ WI +
Sbjct: 218 LSWIKKTM 225
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDT-SSGVSIEIERPIIHEQ 198
CGG+L+ + +V++AAHC Y+ + V +G +++ T S I R I H
Sbjct: 44 FCGGSLVNENWVVSAAHC--------YKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPN 95
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 96 YSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSCAPAGTMCT-----VSGWGNTMSSTAD 150
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
S KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 151 SNKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ 207
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 208 ----GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 240
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M + CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG-------------CGGALYAQDIVLTAAHCVS--GSGNN 45
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + Y K D AL +L QPI
Sbjct: 46 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGYNGTGK--DWALIKL---------AQPIN 93
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR + N N
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVAN 152
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDT--KYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
E I CAG M+ D ++ +G+VS+G CA G+PGVYT V+
Sbjct: 153 EEI-CAGYPDTGGVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVST 211
Query: 346 YIQWIA 351
+ IA
Sbjct: 212 FASAIA 217
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDT-SSGVSIEIERPIIHEQY 199
CGG+L+ + +V++AAHC V +G +++ T S I R I H Y
Sbjct: 24 FCGGSLVNENWVVSAAHCYKSRVA-------VRLGEHNIKVTEGSEQFISSSRVIRHPNY 76
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 77 SSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPAGTMCT-----VSGWGNTMSSTADG 131
Query: 260 PKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 132 DKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ- 187
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ---GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDT-SSGVSIEIERPIIHEQ 198
CGG+L+ + +V++AAHC Y+ + V +G +++ T S I R I H
Sbjct: 24 FCGGSLVNENWVVSAAHC--------YKSRVEVRLGEHNIKVTEGSEQFISSSRVIRHPN 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 76 YSSYNIDNDIMLIKLSKSATLNTYVQPVALPSSCAPAGTMCT-----VSGWGNTMSSTAD 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 131 KNKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ 187
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ----GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/278 (27%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 97 CG--VNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLT 154
CG VN ++I+GG ++ G +PW R GGAL+ R++LT
Sbjct: 145 CGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNIHGRG-----------GGALLGDRWILT 193
Query: 155 AAHCVSPDTTGEYEPYI-----VHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN--- 206
AAH + P E+E V +G ++E+ + I R +H Y N
Sbjct: 194 AAHTLYPK---EHEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEG 250
Query: 207 DIALFRLREDAPLSDLIQPICLP-----YDTNLRSELFERKTPFVAGWGSTVFRGPLSPK 261
DIAL L L + PICLP YD L +V+G+G V ++
Sbjct: 251 DIALLELENSVTLGPNLLPICLPDNDTFYDLGLMG--------YVSGFG--VMEEKIAHD 300
Query: 262 LRHVQISVVDNPKCRQIF--SNYGATINENILCAG--VLXXXXXXXXXXXXXPLMYPLDT 317
LR V++ V + C N ++N+ CAG L + P
Sbjct: 301 LRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTD 360
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++ G+VS+G C+ G+ G YT+V NY+ WI +
Sbjct: 361 RWVATGIVSWGIGCSR-GY-GFYTKVLNYVDWIKKEME 396
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 71/246 (28%), Positives = 104/246 (42%), Gaps = 31/246 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M + CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG-------------CGGALYAQDIVLTAAHCVSG--SGNN 45
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ SG ++++ S + L +D L L QPI
Sbjct: 46 TSITATGGVVDLQ---SGAAVKVR---------STKVLQAPGYNGTGKDWALIKLAQPIN 93
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR + N N
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVAN 152
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDT--KYYIIGVVSYGKKCAEVGFPGVYTRVTN 345
E I CAG M+ D ++ +G+VS+G CA G+PGVYT V+
Sbjct: 153 EEI-CAGYPDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVST 211
Query: 346 YIQWIA 351
+ IA
Sbjct: 212 FASAIA 217
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 33/251 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E P+ ++ CGG+LI +++V++A HC Y
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYH----------FCGGSLINEQWVVSAGHC--------Y 42
Query: 168 EPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ I V +G ++E I + I H QY NDI L +L A ++ +
Sbjct: 43 KSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVST 102
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGA 284
I LP + ++GWG+T G P +L+ + V+ KC ++Y
Sbjct: 103 ISLP-----TAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCE---ASYPG 154
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
I N+ C G L P++ + GVVS+G CA+ PGVYT+V
Sbjct: 155 KITSNMFCVGFLEGGKDSCQGDAGGPVV----CNGQLQGVVSWGDGCAQKNKPGVYTKVY 210
Query: 345 NYIQWIADNIS 355
NY++WI + I+
Sbjct: 211 NYVKWIKNTIA 221
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT S+ P+MA + +NG P CGG LI + +VLTAAHC T
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVT----SNG-PSKFCGGFLIRRNFVLTAAHCAGRSIT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E+ + +E+ + H +Y ++ +DI L +L+E A L+ + +
Sbjct: 53 ----VTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
P N + + VAGWG T P S L+ V++ ++D C F ++ +
Sbjct: 109 PFPSQFNF---VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDHNL 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
LC G PL+ + G+VSYG+ A+ P V+TR+++Y
Sbjct: 165 Q---LCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAKP--PAVFTRISHY 215
Query: 347 IQWI 350
WI
Sbjct: 216 RPWI 219
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 76/249 (30%), Positives = 119/249 (47%), Gaps = 27/249 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+ G + G +P+ A + ++ +R W CGG+LI +++LTAAHCV +
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRR----VW-CGGSLIDNKWILTAAHCVHDAVS--- 52
Query: 168 EPYIVHVGS-IDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+V++GS + E + + ER I H + LND+AL ++ +D IQPI
Sbjct: 53 --VVVYLGSAVQYEGEA---VVNSERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPI 106
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP L ++ FE V+GWG + + L++ V+DN +C Q + I
Sbjct: 107 RLPSGEELNNK-FENIWATVSGWGQS---NTDTVILQYTYNLVIDNDRCAQEYPP--GII 160
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSY--GKKCAEVGFPGVYTRVT 344
E+ +C G P + L K +IGVVS+ G C E G P ++RVT
Sbjct: 161 VESTIC-GDTSDGKSPCFGDSGGPFV--LSDKNLLIGVVSFVSGAGC-ESGKPVGFSRVT 216
Query: 345 NYIQWIADN 353
+Y+ WI N
Sbjct: 217 SYMDWIQQN 225
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CA L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAYGLEGKGDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G C PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCQAKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDT-SSGVSIEIERPIIHEQY 199
CGG+L+ + +V++AAHC V +G +++ T S I R I H Y
Sbjct: 24 FCGGSLVNENWVVSAAHCYKTRVE-------VRLGEHNIKVTEGSEQFISSSRVIRHPNY 76
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 77 SSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPAGTMCT-----VSGWGNTMSSTADK 131
Query: 260 PKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 132 NKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ- 187
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ---GVVSWGYGCAEPGNPGVYAKVCIFNNWLTSTMA 220
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDT-SSGVSIEIERPIIHEQY 199
CGG+L+ + +V++AAHC V +G +++ T S I R I H Y
Sbjct: 24 FCGGSLVNENWVVSAAHCYKSRVE-------VRLGEHNIKVTEGSEQFISSSRVIRHPNY 76
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+S NDI L +L + A L+ +QP+ LP + V+GWG+T+
Sbjct: 77 SSYNIDNDIMLIKLSKPATLNTYVQPVALPSSCAPAGTMCT-----VSGWGNTMSSTADK 131
Query: 260 PKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
KL+ + I ++ C +Y I + CAG L P++ + +
Sbjct: 132 NKLQCLNIPILSYSDCNN---SYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGELQ- 187
Query: 320 YIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
GVVS+G CAE G PGVY +V + W+ ++
Sbjct: 188 ---GVVSWGYGCAEPGNPGVYAKVCIFNDWLTSTMA 220
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S Y I N+ CAG+ P+
Sbjct: 131 YPDVLKCLKAPILSDSSCK---SAYPGQITSNMFCAGLEGGDSCQGDSGG------PVVC 181
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 182 SGKLQGIVSWGSGCAK-NKPGVYTKVCNYVSWIKQTIA 218
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 72/245 (29%), Positives = 104/245 (42%), Gaps = 30/245 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M + CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG-------------CGGALYAQDIVLTAAHCVSG--SGNN 45
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + Y K D AL + L QPI
Sbjct: 46 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGYNGTGK--DWALIK---------LAQPIN 93
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR + N N
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVAN 152
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI-IGVVSYGKKCAEVGFPGVYTRVTNY 346
E I CAG P+ + +I +G+VS+G+ CA G GVYT V+ +
Sbjct: 153 EEI-CAGYDTGGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTF 211
Query: 347 IQWIA 351
IA
Sbjct: 212 ASAIA 216
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT + P+MA + +NG P CGG LI + +VLTAAHC T
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVT----SNG-PSKFCGGFLIRRNFVLTAAHCAGRSIT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E+ + +E+ + H +Y ++ +DI L +L+E A L+ + +
Sbjct: 53 ----VTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
P N + + VAGWG T P S L+ V++ ++D C F ++ +
Sbjct: 109 PFPSQKNF---VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDHNL 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
LC G PL+ + G+VSYG+ A+ P V+TR+++Y
Sbjct: 165 Q---LCVGNPRKTKSAFKGDSGGPLLCAGAAQ----GIVSYGRSDAKP--PAVFTRISHY 215
Query: 347 IQWI 350
WI
Sbjct: 216 QPWI 219
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 24/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG +E P+MA++ NG +CGG L+ +++VL+AAHC+ G+
Sbjct: 1 ILGGREAEAHARPYMASVQL-------NGAH--LCGGVLVAEQWVLSAAHCLEDAADGKV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ L + ++ R + H Y +D+ L +L E A L ++P
Sbjct: 52 Q---VLLGAHSLSQPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVRP- 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP+ R ++ VAGWG G L+HV + V+D C + + GA I
Sbjct: 108 -LPWQRVDR-DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-I 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
E ++CA PL + GVVS+G + C PG+YTRV +
Sbjct: 165 TERLMCA------ESNRRDSCKGDSGGPLVCGGVLEGVVSWGSRVCGNRKKPGIYTRVAS 218
Query: 346 YIQWI 350
Y WI
Sbjct: 219 YAAWI 223
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 73/252 (28%), Positives = 117/252 (46%), Gaps = 23/252 (9%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
I+GG P+MA+I + +CGG LI ++VLTAAHC T G+
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHH---------VCGGVLIDPQWVLTAAHCQYRFTKGQ 52
Query: 167 YEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
++ S+ ++ +S ++EI++ I + TS + NDI L +L+ A L+ ++ +
Sbjct: 53 SPTVVLGAHSLS-KNEASKQTLEIKKFIPFSRVTSDPQSNDIMLVKLQTAAKLNKHVKML 111
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPK--LRHVQISVVDNPKCR-QIFSNYG 283
+ T+LRS + V GWG+T L P LR V ++V+ C Q + N
Sbjct: 112 HIRSKTSLRSGTKCK----VTGWGAT-DPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGD 166
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRV 343
I ++++CAG PL+ K +VS G +C PG+YT +
Sbjct: 167 PFITKDMVCAGDAKGQKDSCKGDAGGPLI----CKGVFHAIVSGGHECGVATKPGIYTLL 222
Query: 344 T-NYIQWIADNI 354
T Y WI N+
Sbjct: 223 TKKYQTWIKSNL 234
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 28/238 (11%)
Query: 126 GFKIRRRRANGKPEW-----MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDL 179
G++ R+ A+ + CGG+LI+ +V++AAHC Y+ I V +G ++
Sbjct: 4 GYECRKNSASYQASLQSGYHFCGGSLISSTWVVSAAHC--------YKSRIQVRLGEHNI 55
Query: 180 E-DTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSEL 238
+ + I+ + I+H Y S NDI L +L + A L+ + + LP S
Sbjct: 56 AVNEGTEQFIDSVKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVSTVALP-----SSCA 110
Query: 239 FERKTPFVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLX 297
V+GWG+ P LR + + ++ + C S Y I N+ CAG +
Sbjct: 111 SSGTRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCN---SAYPGQITSNMFCAGFME 167
Query: 298 XXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
P++ + GVVS+G CA+ PGVYT+V NY WI+ +S
Sbjct: 168 GGKDSCQGDSGGPVV----CNGQLQGVVSWGYGCAQRNKPGVYTKVCNYRSWISSTMS 221
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT + P+MA + +NG P CGG LI + +VLTAAHC T
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVT----SNG-PSKFCGGFLIRRNFVLTAAHCAGRSIT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E+ + +E+ + H +Y ++ +DI L +L+E A L+ + +
Sbjct: 53 ----VTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
P N + + VAGWG T P S L+ V++ ++D C F ++ +
Sbjct: 109 PFPSQFNF---VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDHNL 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
LC G PL+ + G+VSYG+ A+ P V+TR+++Y
Sbjct: 165 Q---LCVGNPRKTKSAFKGDSGGPLLCAGAAQ----GIVSYGRSDAKP--PAVFTRISHY 215
Query: 347 IQWI 350
WI
Sbjct: 216 QPWI 219
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 106/245 (43%), Gaps = 28/245 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGGT + +G++P+M + CGGAL + VLTAAHCVS +G
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG-------------CGGALYAQDIVLTAAHCVSG--SGNN 45
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
G +DL+ +SS V + + + +T D AL + L QPI
Sbjct: 46 TSITATGGVVDLQ-SSSAVKVRSTKVLQAPGFTKETYGKDWALIK---------LAQPIN 95
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
P + + + T VAGWG+ G L + V + CR S++ N
Sbjct: 96 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRS-SSSFILVAN 154
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI-IGVVSYGKKCAEVGFPGVYTRVTNY 346
E ++CAG P+ + ++ +G+VS+G+ CA G GVYT V+ +
Sbjct: 155 E-MICAGYDTKQEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTF 213
Query: 347 IQWIA 351
IA
Sbjct: 214 ASAIA 218
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT + P+MA + +NG P CGG LI + +VLTAAHC T
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVT----SNG-PSKFCGGFLIRRNFVLTAAHCAGRSIT--- 52
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E+ + +E+ + H +Y ++ +DI L +L+E A L+ + +
Sbjct: 53 ----VTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
P N + + VAGWG T P S L+ V++ ++D C F ++ +
Sbjct: 109 PFPSQFNF---VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDHNL 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
LC G PL+ + G+VSYG+ A+ P V+TR+++Y
Sbjct: 165 Q---LCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAKP--PAVFTRISHY 215
Query: 347 IQWI 350
WI
Sbjct: 216 RPWI 219
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 26/244 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT + P+MA + +NG P CGG LI + +VLTAAHC T
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVT----SNG-PSKFCGGFLIRRNFVLTAAHCAGRSIT--- 54
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E+ + +E+ + H +Y ++ +DI L +L+E A L+ + +
Sbjct: 55 ----VTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 110
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
P N + + VAGWG T P S L+ V++ ++D C F ++ +
Sbjct: 111 PFPSQFNF---VPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSH-FRDFDHNL 166
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
LC G PL+ + G+VSYG+ A+ P V+TR+++Y
Sbjct: 167 Q---LCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAKP--PAVFTRISHY 217
Query: 347 IQWI 350
WI
Sbjct: 218 RPWI 221
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S A I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASS---AIITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 26/248 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + F + R CGG L+ K +VLTAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKR------CGGILVRKDFVLTAAHCQGSSIN--- 51
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E + I ++RPI H Y NDI L +L A + ++P+
Sbjct: 52 ----VTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPL 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP ++++ + VAGWG V L+ L+ V ++V + +C ++F +G
Sbjct: 108 RLPSS---KAQVKPGQLCSVAGWG-YVSMSTLATTLQEVLLTVQKDCQCERLF--HGNYS 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+C G PL+ K G++SYG K PGVY +V+++
Sbjct: 162 RATEICVGDPKKTQTGFKGDSGGPLV----CKDVAQGILSYGNKKGTP--PGVYIKVSHF 215
Query: 347 IQWIADNI 354
+ WI +
Sbjct: 216 LPWIKRTM 223
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S+Y I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSY--IITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 42/262 (16%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E+ PW A+ R +++CGG L+ +VLTAAHC
Sbjct: 1 IVGGFKCEKNSQPWHVAV-----YRYT----QYLCGGVLLDPNWVLTAAHCYD------- 44
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSA--RK---------LNDIALFRLRE 215
+ Y V +G +L +D S + + I H + + RK ND+ L RL +
Sbjct: 45 DNYKVWLGKNNLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSK 104
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-TVFRGPLSPKLRHVQISVVDNPK 274
A ++D ++PI LP + E T +GWGS T + + L V + ++ N
Sbjct: 105 PADITDTVKPITLPTE-----EPKLGSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNED 159
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAE 333
C + + + + +LCAG + PL+ + G+ S+G C E
Sbjct: 160 CAKA---HIEKVTDAMLCAGEMDGGKDTCKGDSGGPLI----CDGVLQGITSWGHTPCGE 212
Query: 334 VGFPGVYTRVTNYIQWIADNIS 355
PGVYT++ + WI D ++
Sbjct: 213 PDMPGVYTKLNKFTSWIKDTMA 234
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDAGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 25/248 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + + K CGG LI +VLTAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYLMI------WDQKSLKRCGGFLIQDDFVLTAAHCWGSSIN--- 51
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E + I ++RPI H Y NDI L +L A + +QP+
Sbjct: 52 ----VTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPL 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP + ++++ +T VAGWG T G S L+ V+++V ++ KC +Y +
Sbjct: 108 RLPSN---KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDST 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
E LC G PL+ G+VSYG+ P T+V+++
Sbjct: 165 IE--LCVGDPEIKKTSFKGDSGGPLV----CNKVAQGIVSYGRNNGMP--PRACTKVSSF 216
Query: 347 IQWIADNI 354
+ WI +
Sbjct: 217 VHWIKKTM 224
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDAGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 25/248 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + + K CGG LI +VLTAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAYLMI------WDQKSLKRCGGFLIRDDFVLTAAHCWGSSIN--- 51
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E + I ++RPI H Y NDI L +L A + +QP+
Sbjct: 52 ----VTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPL 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP + ++++ +T VAGWG T G S L+ V+++V ++ KC +Y +
Sbjct: 108 RLPSN---KAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDST 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
E LC G PL+ G+VSYG+ P T+V+++
Sbjct: 165 IE--LCVGDPEIKKTSFKGDSGGPLV----CNKVAQGIVSYGRNNGMP--PRACTKVSSF 216
Query: 347 IQWIADNI 354
+ WI +
Sbjct: 217 VHWIKKTM 224
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PG+YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGIYTKVCNYVSWIKQTIA 221
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 24/246 (9%)
Query: 107 RIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGE 166
RI+GG +E P+MA++ NG +CGG L+ +++VL+AAHC+ G+
Sbjct: 7 RILGGREAEAHARPYMASVQL-------NGA--HLCGGVLVAEQWVLSAAHCLEDAADGK 57
Query: 167 YEPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
+ V +G+ L + ++ R + H +D+ L +L E A L ++P
Sbjct: 58 VQ---VLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRP 114
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT 285
LP+ R ++ VAGWG G L+HV + V+D C + + GA
Sbjct: 115 --LPWQRVDR-DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA- 170
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVT 344
I E ++CA PL + GVV+ G + C PG+YTRV
Sbjct: 171 ITERLMCA------ESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVA 224
Query: 345 NYIQWI 350
+Y WI
Sbjct: 225 SYAAWI 230
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSW--IITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 26/248 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ P+MA + F + R CGG L+ K +VLTAAHC
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKR------CGGILVRKDFVLTAAHCQGSSIN--- 51
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ ++ E + I ++RPI H Y N+I L +L A + ++P+
Sbjct: 52 ----VTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPL 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP ++++ + VAGWG V L+ L+ V ++V + +C ++F +G
Sbjct: 108 RLPSS---KAQVKPGQLCSVAGWG-YVSMSTLATTLQEVLLTVQKDCQCERLF--HGNYS 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
+C G PL+ K G++SYG K PGVY +V+++
Sbjct: 162 RATEICVGDPKKTQTGFKGDSGGPLV----CKDVAQGILSYGNKKGTP--PGVYIKVSHF 215
Query: 347 IQWIADNI 354
+ WI +
Sbjct: 216 LPWIKRTM 223
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSNTLNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P L+ ++ ++ + C+ S I N+ CAG L P++
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSR---IITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKL 187
Query: 318 KYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 188 Q----GIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIA 221
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E P+ ++ CGG+LI++++V++AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGYH----------FCGGSLISEQWVVSAAHCYKTRIQVRL 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ + V LE I + I H +Y NDI L +L A ++ + I
Sbjct: 51 GEHNIKV----LEGNEQ--FINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTIS 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATI 286
LP + ++GWG+T+ G P +L+ + V+ +C+ ++Y I
Sbjct: 105 LP-----TAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECK---ASYPGKI 156
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
++ C G L P++ + GVVS+G CA PGVYT+V NY
Sbjct: 157 TNSMFCVGFLEGGKDSCQRDAGGPVV----CNGQLQGVVSWGHGCAWKNRPGVYTKVYNY 212
Query: 347 IQWIADNIS 355
+ WI D I+
Sbjct: 213 VDWIKDTIA 221
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 24/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG +E P+MA++ + NG E +CGG L+ +++VL+AAHC+ G+
Sbjct: 1 ILGGREAEAHARPYMASV-------QVNG--EHLCGGVLVAEQWVLSAAHCLEDAADGKV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ L + ++ R + H +D+ L +L E A L ++P
Sbjct: 52 Q---VLLGAHSLSQPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVRP- 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP+ R ++ VAGWG G +L+HV + V+D C + + GA I
Sbjct: 108 -LPWQRVDR-DVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGA-I 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
+ ++CA PL + GVV+ G + C PG+YTRV +
Sbjct: 165 TQRMMCA------ESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVAS 218
Query: 346 YIQWI 350
Y WI
Sbjct: 219 YAAWI 223
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG+YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIA 221
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 76/261 (29%), Positives = 114/261 (43%), Gaps = 42/261 (16%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E+ PW + R RA +CGG L+ ++VLTAAHC+ +
Sbjct: 1 IVGGWECEKHSQPWQVLVA---SRGRA------VCGGVLVHPQWVLTAAHCIRNKS---- 47
Query: 168 EPYIVHVGSIDL---EDTSS--GVSIEIERPIIHEQYTSARKL-------NDIALFRLRE 215
++ +G L EDT VS P+ R L +D+ L RL E
Sbjct: 48 ---VILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSE 104
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPK 274
A L+D ++ + LP E T + +GWGS L+P KL+ V + V+ N
Sbjct: 105 PAELTDAVKVMDLP-----TQEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDV 159
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAE 333
C Q+ + + + +LCAG PL+ + G+ S+G + CA
Sbjct: 160 CAQV---HPQKVTKFMLCAGRWTGGKSTCSGDSGGPLV----CNGVLQGITSWGSEPCAL 212
Query: 334 VGFPGVYTRVTNYIQWIADNI 354
P +YT+V +Y +WI D I
Sbjct: 213 PERPSLYTKVVHYRKWIKDTI 233
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E P+ ++ CGG+LI++++V++AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSLN----------SGSHFCGGSLISEQWVVSAAHCYKTRIQVRL 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ + V LE I + I H +Y NDI L +L A ++ + I
Sbjct: 51 GEHNIKV----LEGNEQ--FINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTIS 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATI 286
LP + ++GWG+T+ G P +L+ + V+ +C+ ++Y I
Sbjct: 105 LP-----TAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECK---ASYPGKI 156
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
++ C G L P++ + GVVS+G CA PGVYT+V NY
Sbjct: 157 TNSMFCVGFLEGGKDSCQRDAGGPVV----CNGQLQGVVSWGHGCAWKNRPGVYTKVYNY 212
Query: 347 IQWIADNIS 355
+ WI D I+
Sbjct: 213 VDWIKDTIA 221
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 72/260 (27%), Positives = 108/260 (41%), Gaps = 43/260 (16%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG ++ G +PW R GGAL+ R++LTAAH + P E+
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGR-----------GGGALLGDRWILTAAHTLYPK---EH 46
Query: 168 EP-----YIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN---DIALFRLREDAPL 219
E V +G ++E+ + I R +H Y N DIAL L L
Sbjct: 47 EAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTL 106
Query: 220 SDLIQPICLP-----YDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPK 274
+ PICLP YD L +V+G+G V ++ LR V++ V +
Sbjct: 107 GPNLLPICLPDNDTFYDLGLMG--------YVSGFG--VMEEKIAHDLRFVRLPVANPQA 156
Query: 275 CRQIF--SNYGATINENILCAG--VLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK 330
C N ++N+ CAG L + P ++ G+VS+G
Sbjct: 157 CENWLRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIG 216
Query: 331 CAEVGFPGVYTRVTNYIQWI 350
C+ G+ G YT+V NY+ WI
Sbjct: 217 CSR-GY-GFYTKVLNYVDWI 234
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 22/247 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+MA F + GK + CGG L+ ++VLTAAHC G
Sbjct: 1 IIGGNEISPHSRPYMAYYEF----LKVGGK-KMFCGGFLVRDKFVLTAAHC-----KGRS 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ +I ++ + + I + + I H Y + NDI L +L +A + ++P+
Sbjct: 51 MTVTLGAHNIKAKEETQQI-IPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLN 109
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP + + +VAGWG G L V+++V + C F + N
Sbjct: 110 LP---RRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRAN 166
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E +C G PL+ K G+VSYG+ + P V+TRV +++
Sbjct: 167 E--ICVGDSKIKGASFEEDSGGPLV----CKRAAAGIVSYGQ--TDGSAPQVFTRVLSFV 218
Query: 348 QWIADNI 354
WI +
Sbjct: 219 SWIKKTM 225
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+L+ ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLLNSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG+YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGIYTKVCNYVSWIKQTIA 221
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDAGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 22/247 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+MA F + GK + CGG L+ ++VLTAAHC G
Sbjct: 1 IIGGNEISPHSRPYMAYYEF----LKVGGK-KMFCGGFLVRDKFVLTAAHC-----KGRS 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ +I ++ + + I + + I H Y + NDI L +L +A + ++P+
Sbjct: 51 MTVTLGAHNIKAKEETQQI-IPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLN 109
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP + + +VAGWG G L V+++V + C F + N
Sbjct: 110 LP---RRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRAN 166
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E +C G PL+ K G+VSYG+ + P V+TRV +++
Sbjct: 167 E--ICVGDSKIKGASFRGDSGGPLV----CKRAAAGIVSYGQ--TDGSAPQVFTRVLSFV 218
Query: 348 QWIADNI 354
WI +
Sbjct: 219 SWIKKTM 225
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 29/249 (11%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E P+ ++ CGG+LI++++V++AAHC
Sbjct: 1 IVGGYTCEENSLPYQVSLN----------SGSHFCGGSLISEQWVVSAAHCYKTRIQVRL 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ + V LE I + I H +Y NDI L +L A ++ + I
Sbjct: 51 GEHNIKV----LEGNEQ--FINAVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTIS 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCRQIFSNYGATI 286
LP + ++GWG+T+ G P +L+ + V+ +C+ ++Y I
Sbjct: 105 LP-----TAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECK---ASYPGKI 156
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNY 346
++ C G L P++ + GVVS+G CA PGVYT+V NY
Sbjct: 157 TNSMFCVGFLEGGKDSCQRDSGGPVV----CNGQLQGVVSWGHGCAWKNRPGVYTKVYNY 212
Query: 347 IQWIADNIS 355
+ WI D I+
Sbjct: 213 VDWIKDTIA 221
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDAGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 109/245 (44%), Gaps = 24/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG +E P+MA++ NG +CGG L+ +++VL+AAHC+ G+
Sbjct: 1 ILGGREAEAHARPYMASVQL-------NGA--HLCGGVLVAEQWVLSAAHCLEDAADGKV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ L + ++ R + H +D+ L +L E A L ++P
Sbjct: 52 Q---VLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRP- 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP+ R ++ VAGWG G L+HV + V+D C + + GA I
Sbjct: 108 -LPWQRVDR-DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-I 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
E ++CA PL + GVV+ G + C PG+YTRV +
Sbjct: 165 TERLMCA------ESNRRDSCKGDAGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVAS 218
Query: 346 YIQWI 350
Y WI
Sbjct: 219 YAAWI 223
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+V G P+ R WM ++ ++ + +CGG+LI + +VLTA C +Y
Sbjct: 1 VVNGIPT-RTNIGWMVSLRYRNKH---------ICGGSLIKESWVLTARQCFPSRDLKDY 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
E ++ + D + ++ + Q + +D+ L +L A L D + I
Sbjct: 51 EAWL------GIHDVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTID 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP N S + E+ + V GWG T LR + ++ N KC Q T+N
Sbjct: 105 LP---NYGSTIPEKTSCSVYGWGYTGLIN-YDGLLRVAHLYIMGNEKCSQHHRGK-VTLN 159
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E+ +CAG PL+ ++GV+ G+ CA PG++ RV Y
Sbjct: 160 ESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYA 219
Query: 348 QWI 350
+WI
Sbjct: 220 KWI 222
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+V G P+ R WM ++ ++ + +CGG+LI + +VLTA C +Y
Sbjct: 1 VVNGIPT-RTNIGWMVSLRYRNKH---------ICGGSLIKESWVLTARQCFPSRDLKDY 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
E ++ + D + ++ + Q + +D+ L +L A L D + I
Sbjct: 51 EAWL------GIHDVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTID 104
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP N S + E+ + V GWG T LR + ++ N KC Q T+N
Sbjct: 105 LP---NYGSTIPEKTSCSVYGWGYTGLIN-YDGLLRVAHLYIMGNEKCSQHHRGK-VTLN 159
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E+ +CAG PL+ ++GV+ G+ CA PG++ RV Y
Sbjct: 160 ESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYA 219
Query: 348 QWI 350
+WI
Sbjct: 220 KWI 222
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 109/245 (44%), Gaps = 24/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG +E P+MA++ NG +CGG L+ +++VL+AAHC+ G+
Sbjct: 1 ILGGREAEAHARPYMASVQL-------NGA--HLCGGVLVAEQWVLSAAHCLEDAADGKV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ L + ++ R + H +D+ L +L E A L ++P
Sbjct: 52 Q---VLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRP- 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP+ R ++ VAGWG G L+HV + V+D C + + GA I
Sbjct: 108 -LPWQRVDR-DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-I 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
E ++CA PL + GVV+ G + C PG+YTRV +
Sbjct: 165 TERLMCA------ESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVAS 218
Query: 346 YIQWI 350
Y WI
Sbjct: 219 YAAWI 223
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 100 NAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV 159
N + +RI+GG+ +G +PW A + I G LI ++++LT A +
Sbjct: 95 NPVDQVQRIMGGSLDAKGSFPWQAKM---ISHHNLTS------GATLINEQWLLTTAKNL 145
Query: 160 ----SPDTTG-EYEPYI-VHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRL 213
DT + P + ++VG +EIE+ I H ++ DI L +L
Sbjct: 146 RLGHKNDTKAKDIAPTLRLYVGKKQ--------EVEIEKVIFHPDNSTV----DIGLIKL 193
Query: 214 REDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNP 273
++ P+++ + PICLP + L +V+GWG + L++V + V D
Sbjct: 194 KQKVPVNERVMPICLPSKDYVNVGLV----GYVSGWGRNANLN-FTEHLKYVMLPVADQE 248
Query: 274 KCRQIFSNYGATI----------------NENILCAGVLXXXXXXXXXXXXXPLMY--PL 315
KC Q + G+T+ NE+ CAG+
Sbjct: 249 KCVQYYE--GSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKD 306
Query: 316 DTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
D +Y G++S+ K C + GVY RVT+ + WI I+
Sbjct: 307 DDTWYAAGILSFDKSCRTAEY-GVYVRVTSILDWIQTTIA 345
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 73/248 (29%), Positives = 110/248 (44%), Gaps = 35/248 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP AA+ + CGG+LI+ ++LTAAHC+ D G
Sbjct: 1 IVGGVEAVPNSWPHQAALFID---------DMYFCGGSLISPEWILTAAHCM--DGAGFV 49
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ ++ ED ++ V+I+ +HE Y S NDIA+ RL L+ I +
Sbjct: 50 D---VVLGAHNIREDEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATV 106
Query: 227 CLP-YDTNLRSELFERKTPFVAGWG--STVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG 283
LP D + + + TP GWG S G +S LR V + ++ N C + YG
Sbjct: 107 GLPSTDVGVGTVV----TP--TGWGLPSDSALG-ISDVLRQVDVPIMSNADCDAV---YG 156
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCA-EVGFPGVYTR 342
+ NI PL+ G+ S+G E G+P +TR
Sbjct: 157 IVTDGNICIDSTGGKGTCNGDSGG------PLNYNGLTYGITSFGAAAGCEAGYPDAFTR 210
Query: 343 VTNYIQWI 350
VT ++ WI
Sbjct: 211 VTYFLDWI 218
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/254 (28%), Positives = 108/254 (42%), Gaps = 22/254 (8%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
++GGT + G++PW ++ ++R +G CG +L++ L+A+HCV G
Sbjct: 1 VIGGTNASPGEFPW------QLSQQRQSGSWSHSCGASLLSSTSALSASHCVD----GVL 50
Query: 168 EPYI-VHVGSIDLEDTSSGVSIEIERPIIHEQYTS--ARKLNDIALFRLREDAPLSDLIQ 224
I V G DTS + ++ +HE Y + A NDIA+ L L IQ
Sbjct: 51 PNNIRVIAGLWQQSDTSGTQTANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQ 110
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYG- 283
LP + N + T ++GWG T L L+ I V+ +C G
Sbjct: 111 AAVLPANNN---NDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGG 167
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSY----GKKCAEVGFPGV 339
A I +N +C PL P D ++GV S+ G +P V
Sbjct: 168 ANIWDNHICVQDPAGNTGACNGDSGGPLNCP-DGGTRVVGVTSWVVSSGLGACLPDYPSV 226
Query: 340 YTRVTNYIQWIADN 353
YTRV+ Y+ WI DN
Sbjct: 227 YTRVSAYLGWIGDN 240
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 31/255 (12%)
Query: 103 NSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPD 162
+ +IVGG + P+ ++ CGG+LI ++V++AAHC
Sbjct: 6 DDDDKIVGGYTCQENSVPYQVSLNSGYH----------FCGGSLINDQWVVSAAHCYKSR 55
Query: 163 TTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDL 222
+ ++V LE V+ + I H + NDI L +L L+
Sbjct: 56 IQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFDRKTLNNDIMLIKLSSPVKLNAR 109
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQI--FS 280
+ + LP S ++GWG+T+ G P L + +D P Q +
Sbjct: 110 VATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEPDL----LQCLDAPLLPQADCEA 160
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVY 340
+Y I +N++C G L P++ + + G+VS+G CA PGVY
Sbjct: 161 SYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVCNGELQ----GIVSWGYGCALPDNPGVY 216
Query: 341 TRVTNYIQWIADNIS 355
T+V NY+ WI D I+
Sbjct: 217 TKVCNYVDWIQDTIA 231
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ CAG L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PG YT++ NY+ WI I+
Sbjct: 189 ----GIVSWGSGCAQKNKPGFYTKLCNYVSWIKQTIA 221
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 31/255 (12%)
Query: 103 NSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPD 162
+ +IVGG + P+ ++ CGG+LI ++V++AAHC
Sbjct: 18 DDDDKIVGGYTCQENSVPYQVSLNSGYH----------FCGGSLINDQWVVSAAHCYKSR 67
Query: 163 TTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDL 222
+ ++V LE V+ + I H + NDI L +L L+
Sbjct: 68 IQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFDRKTLNNDIMLIKLSSPVKLNAH 121
Query: 223 IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQI--FS 280
+ + LP S ++GWG+T+ G P L + +D P Q +
Sbjct: 122 VATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEPDL----LQCLDAPLLPQADCEA 172
Query: 281 NYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVY 340
+Y I +N++C G L P++ + + G+VS+G CA PGVY
Sbjct: 173 SYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ----GIVSWGYGCALPDNPGVY 228
Query: 341 TRVTNYIQWIADNIS 355
T+V NY+ WI D I+
Sbjct: 229 TKVCNYVDWIQDTIA 243
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+L++K +V++AAHC + + V + SS I H Y+
Sbjct: 24 FCGGSLVSKDWVVSAAHCYKSVLRVRLGEHHIRVNEGTEQYISS------SSVIRHPNYS 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
S NDI L +L + A L+ + + LP + + + V+GWG+T+
Sbjct: 78 SYNINNDIMLIKLTKPATLNQYVHAVALPTECAADATMCT-----VSGWGNTMSSVADGD 132
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
KL+ + + ++ + C ++Y I +++ CAG L P++
Sbjct: 133 KLQCLSLPILSHADCA---NSYPGMITQSMFCAGYLEGGKDSCQGDSGGPVV----CNGV 185
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ GVVS+G CAE PGVY +V W+ D ++
Sbjct: 186 LQGVVSWGYGCAERDHPGVYAKVCVLSGWVRDTMA 220
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L+ + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLNSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ C G L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 108/245 (44%), Gaps = 24/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG +E P+MA++ NG +CGG L+ +++VL+AAHC+ G+
Sbjct: 1 ILGGREAEAHARPYMASVQL-------NGA--HLCGGVLVAEQWVLSAAHCLEDAADGKV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+ V +G+ L + ++ R + H +D+ L +L E A L ++P
Sbjct: 52 Q---VLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRP- 107
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP+ R ++ VAGWG G L+HV + V+D C + + GA I
Sbjct: 108 -LPWQRVDR-DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGA-I 164
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
E ++CA PL + GVV+ G C PG+YTRV +
Sbjct: 165 TERLMCA------ESNRRDSCKGDSGGPLVCGGVLEGVVTSGSAVCGNRKKPGIYTRVAS 218
Query: 346 YIQWI 350
Y WI
Sbjct: 219 YAAWI 223
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKSSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 HKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 32 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 85
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 86 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 140
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++
Sbjct: 141 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGNSGGPVV----CN 192
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 193 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 229
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVGSIDLEDTSSGVS-IEIERPIIHEQ 198
CGG+LI ++V++AAHC Y+ I V +G ++ I + I+H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSGIQVRLGEDNINVVEGNEQFISASKSIVHPS 75
Query: 199 YTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPL 258
Y S NDI L +L+ A L + I LP S ++GWG+T G
Sbjct: 76 YNSETYNNDIMLIKLKSAASLXSRVASISLP-----TSCASAGTQCLISGWGNTKSSGTS 130
Query: 259 SPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + + + + S++ I N+ C G L P++ +
Sbjct: 131 YPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVGYLEGGKDACQGDSGGPVVCSGKLQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G+ CA+ PG YT+V NY+ WI I+
Sbjct: 189 ----GIVSWGEGCAQKNKPGFYTKVCNYVSWIKQTIA 221
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 32 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 85
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 86 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 140
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++
Sbjct: 141 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVV----CN 192
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 193 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 229
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDAGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 32 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 85
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 86 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 140
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++
Sbjct: 141 DL----LKCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVV----CN 192
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 193 GELQGIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 229
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RETYNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 75.1 bits (183), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 34 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 87
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 88 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 142
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 143 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 198
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 199 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 231
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + I LP S ++GWG T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATIALP-----SSCAPAGTQCLISGWGHTLSSGVNHP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQ--IFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDCGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 42/261 (16%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG E+ PW A+ ++ E +CGG L+ + +VLTAAHC
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQ---------KEHICGGVLLDRNWVLTAAHCY-------V 44
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSARKL-----------NDIALFRLRE 215
+ Y V +G L ++ S + + H + + + +D+ L RL +
Sbjct: 45 DQYEVWLGKNKLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSK 104
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-TVFRGPLSPKLRHVQISVVDNPK 274
A ++D+++PI LP E +GWGS T R L+ V I+++ N
Sbjct: 105 PADITDVVKPIALP-----TKEPKPGSKCLASGWGSITPTRWQKPDDLQCVFITLLPNEN 159
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAE 333
C ++ Y + + +LCAG + PL+ + G SYG C +
Sbjct: 160 CAKV---YLQKVTDVMLCAGEMGGGKDTCRDDSGGPLI----CDGILQGTTSYGPVPCGK 212
Query: 334 VGFPGVYTRVTNYIQWIADNI 354
G P +YT + + WI D +
Sbjct: 213 PGVPAIYTNLIKFNSWIKDTM 233
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGHTLSSGVNHP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+V +G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVEWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+V +G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVKWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW AA+ F+ R +CGG L+ R+VLTAAHC + + Y V +G L
Sbjct: 13 PWQAAL-FQGERL--------ICGGVLVGDRWVLTAAHC-------KKQKYSVRLGDHSL 56
Query: 180 EDTSS-GVSIEIERPIIHEQYTSAR---KLNDIALFRLREDAPLSDLIQPICLPYDTNLR 235
+ I++ + I H Y ++ +DI L RL+ A L D ++P+ L NL
Sbjct: 57 QSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQL---ANLC 113
Query: 236 SELFERKTPFVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNYGATINENILCAG 294
++ ++ ++GWG+ P L ++ + KC + Y I E ++CAG
Sbjct: 114 PKVGQK--CIISGWGTVTSPQENFPNTLNCAEVKIYSQNKCERA---YPGKITEGMVCAG 168
Query: 295 VLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADN 353
PL + G+ S+G C + PGVYT++ Y WI
Sbjct: 169 SSNGADTCQGDSGG-----PLVCDGMLQGITSWGSDPCGKPEKPGVYTKICRYTTWIKKT 223
Query: 354 I 354
+
Sbjct: 224 M 224
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V D + + + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGDEQ------FVNAAKIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
N+I L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNNIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
N+I L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNNIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKDSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/251 (26%), Positives = 108/251 (43%), Gaps = 25/251 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+M + + +C GALI K +VLTAAHC +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKT---------ICAGALIAKDWVLTAAHC----NLNKR 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
I+ SI E+ + + + +++ + Y A + D+ L +L E A ++ + +
Sbjct: 48 SQVILGAHSITREEPTKQIML-VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILH 106
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCR-QIFSNYGATI 286
LP + ++ VAGWG T S LR V+I+++D C + N+ I
Sbjct: 107 LPKKGD---DVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVI 163
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYG--KKCAEVGFPGVYTRVT 344
N++CAG L PL+ + GV S+G KC + PGVY ++
Sbjct: 164 GMNMVCAGSLRGGRDSCNGDSGSPLL----CEGVFRGVTSFGLENKCGDPRGPGVYILLS 219
Query: 345 -NYIQWIADNI 354
++ WI I
Sbjct: 220 KKHLNWIIMTI 230
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 139 EWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSID-LEDTSSGVSIEIERPIIHE 197
++ CGG L+ + +VLTAAHC + + Y V +G + LED S + + I H
Sbjct: 26 KYQCGGVLLDRNWVLTAAHCYN-------DKYQVWLGKNNFLEDEPSDQHRLVSKAIPHP 78
Query: 198 QYTSA-----------RKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFV 246
+ + ND+ L RL + A ++D+++PI LP + E T
Sbjct: 79 DFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTE-----EPKLGSTCLA 133
Query: 247 AGWGSTV---FRGPLSPKLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXX 303
+GWGST F+ P L+ V + ++ N C + + + + +LCAG +
Sbjct: 134 SGWGSTTPIKFKYP--DDLQCVNLKLLPNEDCDKA---HEMKVTDAMLCAGEMDGGSYTC 188
Query: 304 XXXXXXPLMYPLDTKYYIIGVVSYG-KKCAEVGFPGVYTRVTNYIQWIADNIS 355
PL+ + G+ S+G + C E P VYT++ + WI + ++
Sbjct: 189 EHDSGGPLI----CDGILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRETMA 237
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 66/251 (26%), Positives = 107/251 (42%), Gaps = 25/251 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+M + + +C GALI K +VLTAAHC +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKT---------ICAGALIAKDWVLTAAHC----NLNKR 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
I+ SI E+ + + + +++ + Y A + D+ L +L E A ++ + +
Sbjct: 48 SQVILGAHSITREEPTKQIML-VKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILH 106
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCR-QIFSNYGATI 286
LP + ++ VAGWG T S LR V I+++D C + N+ I
Sbjct: 107 LPKKGD---DVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVI 163
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYG--KKCAEVGFPGVYTRVT 344
N++CAG L PL+ + GV S+G KC + PGVY ++
Sbjct: 164 GMNMVCAGSLRGGRDSCNGDSGSPLL----CEGVFRGVTSFGLENKCGDPRGPGVYILLS 219
Query: 345 -NYIQWIADNI 354
++ WI I
Sbjct: 220 KKHLNWIIMTI 230
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RETYNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQIFSNYGAT--INENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++ I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA PGVYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPGVYTKVCNYVDWIQDTIA 221
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 25/228 (10%)
Query: 135 NGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIE 191
N + GG+LI ++V++AAHC Y+ I V +G +ID+ + + I
Sbjct: 20 NSGSHFCSGGSLINSQWVVSAAHC-------SYKSRIQVRLGEHNIDVLEGNEQF-INAA 71
Query: 192 RPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS 251
+ I H + NDI L +L A L+ + + LP + ++GWG+
Sbjct: 72 KIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSC----AAAGTECSLISGWGN 127
Query: 252 TVFRGPLSPKLRHVQIS--VVDNPKCRQIFSNYGATINENILCAGVLXXXXXX-XXXXXX 308
T G P L + V+ + C+ S+Y I N++C G L
Sbjct: 128 TKSSGSSYPSLLQCSLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCSQGDSG 184
Query: 309 XPLMYPLDTKYYIIGVVSYGKKC-AEVGFPGVYTRVTNYIQWIADNIS 355
P++ + + G+VS+G C A+ PGVYT+V NY+ WI I+
Sbjct: 185 GPVVC---SNGQLQGIVSWGYGCSAQKNKPGVYTKVCNYVNWIQQTIA 229
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG+LI ++V++AAHC + ++V LE V+ + I H +
Sbjct: 24 FCGGSLINDQWVVSAAHCYKSRIQVRLGEHNINV----LEGNEQFVNAA--KIIKHPNFD 77
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
NDI L +L L+ + + LP S ++GWG+T+ G P
Sbjct: 78 RKTLNNDIMLIKLSSPVKLNARVATVALP-----SSCAPAGTQCLISGWGNTLSSGVNEP 132
Query: 261 KLRHVQISVVDNPKCRQI--FSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
L + +D P Q ++Y I +N++C G L P++ + +
Sbjct: 133 DL----LQCLDAPLLPQADCEASYPGKITDNMVCVGFLEGGKGSCQGDSGGPVVCNGELQ 188
Query: 319 YYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA P VYT+V NY+ WI D I+
Sbjct: 189 ----GIVSWGYGCALPDNPDVYTKVCNYVDWIQDTIA 221
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 37/260 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E+ PW AA+ + + CGG L+ +++VLTAAHC+S + Y
Sbjct: 1 IVGGWECEQHSQPWQAAL-YHFSTFQ--------CGGILVHRQWVLTAAHCISDN----Y 47
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPII---------HEQYTSARKLNDIALFRLREDA- 217
+ ++ D E+T+ V + P H + +D+ L RL E A
Sbjct: 48 QLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPAD 107
Query: 218 PLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP-KLRHVQISVVDNPKCR 276
++D ++ + LP + E T +GWGS P L+ V + ++ N +C+
Sbjct: 108 TITDAVKVVELPTE-----EPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECK 162
Query: 277 QIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVG 335
+ + + + +LC G L PLM + GV S+G C
Sbjct: 163 KA---HVQKVTDFMLCVGHLEGGKDTCVGDSGGPLM----CDGVLQGVTSWGYVPCGTPN 215
Query: 336 FPGVYTRVTNYIQWIADNIS 355
P V RV +Y++WI D I+
Sbjct: 216 KPSVAVRVLSYVKWIEDTIA 235
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 32/250 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+ G PW AA+ + E C G L+ ++VL+AAHC
Sbjct: 1 IINGEDCSPHSQPWQAALVME---------NELFCSGVLVHPQWVLSAAHCFQ------- 44
Query: 168 EPYIVHVG--SIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
Y + +G S++ + +E + H +Y ND+ L +L E SD I+
Sbjct: 45 NSYTIGLGLHSLEADQEPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRS 104
Query: 226 ICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGAT 285
I + + V+GWG + G + L+ V +SVV C ++ Y
Sbjct: 105 ISIASQCPTAG-----NSCLVSGWG-LLANGRMPTVLQCVNVSVVSEEVCSKL---YDPL 155
Query: 286 INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVT 344
+ ++ CAG PL+ Y+ G+VS+GK C +VG PGVYT +
Sbjct: 156 YHPSMFCAGGGQDQKDSCNGDSGGPLI----CNGYLQGLVSFGKAPCGQVGVPGVYTNLC 211
Query: 345 NYIQWIADNI 354
+ +WI +
Sbjct: 212 KFTEWIEKTV 221
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 23/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+MA++ + NG +CGG L+ ++VLTAAHC++
Sbjct: 1 IIGGREVIPHSRPYMASL-------QRNG--SHLCGGVLVHPKWVLTAAHCLAQRMAQLR 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLREDAPLSDLIQPI 226
++ + ++D S G++ I+ I H +Y L ND+AL +L S I+P+
Sbjct: 52 --LVLGLHTLD----SPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPL 105
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP R + +AGWG T G LS LR + + V+D C + ++
Sbjct: 106 ALPSK---RQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNN-SRFWNGSL 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
+ +++C PL+ + GV+S+ + C ++ P V T V
Sbjct: 162 SPSMVCLAADSKDQAPCKGDSGGPLV--CGKGRVLAGVLSFSSRVCTDIFKPPVATAVAP 219
Query: 346 YIQWI 350
Y+ WI
Sbjct: 220 YVSWI 224
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 71/263 (26%), Positives = 106/263 (40%), Gaps = 57/263 (21%)
Query: 110 GGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT-- 164
GG ++ Q PW A+ R G+ CGGA++++ +VLTAAHCV P+T
Sbjct: 2 GGEKTDIKQVPWTVAV------RTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETIVI 55
Query: 165 -----------GEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRL 213
G+ +PY+ HV Y NDIA+ L
Sbjct: 56 QYESTNLWEDPGKSDPYVSHV--------------------YLSFYRQETMENDIAILEL 95
Query: 214 REDAPLSDL-IQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDN 272
L L +P LP D R + V+G+G P L+ Q++VVD
Sbjct: 96 SRPLKLDGLKSKPAKLP-DIEFRPKT--GSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDL 152
Query: 273 PKCRQIFSNYGAT-INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKC 331
+CR + YG ++ + CA + P + ++GV +Y K
Sbjct: 153 DECR---TKYGPIFLSLQVFCAQKVGVSLESGDAGD------PTVQQDTLVGVAAYFPKR 203
Query: 332 AEVGFPGVYTRVTNYIQWIADNI 354
E G P V+T+V +Y+ WI D I
Sbjct: 204 PE-GAPEVFTKVGSYVSWIQDII 225
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 72/246 (29%), Positives = 103/246 (41%), Gaps = 36/246 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + Q+P++A+I + R CGGALI R+V+TAA C G
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRH---------FCGGALIHARFVMTAASCFQSQNPGV- 50
Query: 168 EPYIVHVGSIDL--EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
V +G+ DL + S + I + Y + LND+ L +L +A L+ +
Sbjct: 51 --STVVLGAYDLRRRERQSRQTFSISS-MSENGYDPQQNLNDLMLLQLDREANLTSSVTI 107
Query: 226 ICLPYDTNLRSELFERKTPF-VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
+ LP L++ E T VAGWGS G LS R V ++V +CR
Sbjct: 108 LPLP----LQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR-------- 155
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
N +C GVL PL+ + GV S+ G P +TRV
Sbjct: 156 ---PNNVCTGVLTRRGGICNGDQGTPLV----CEGLAHGVASFSLGPCGRG-PDFFTRVA 207
Query: 345 NYIQWI 350
+ WI
Sbjct: 208 LFRDWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 72/246 (29%), Positives = 103/246 (41%), Gaps = 36/246 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + Q+P++A+I + R CGGALI R+V+TAA C G
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRH---------FCGGALIHARFVMTAASCFQSQNPGV- 50
Query: 168 EPYIVHVGSIDL--EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
V +G+ DL + S + I + Y + LND+ L +L +A L+ +
Sbjct: 51 --STVVLGAYDLRRRERQSRQTFSISS-MSENGYDPQQNLNDLMLLQLDREANLTSSVTI 107
Query: 226 ICLPYDTNLRSELFERKTPF-VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
+ LP L++ E T VAGWGS G LS R V ++V +CR
Sbjct: 108 LPLP----LQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR-------- 155
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
N +C GVL PL+ + GV S+ G P +TRV
Sbjct: 156 ---PNNVCTGVLTRRGGICNGDGGTPLV----CEGLAHGVASFSLGPCGRG-PDFFTRVA 207
Query: 345 NYIQWI 350
+ WI
Sbjct: 208 LFRDWI 213
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 23/245 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG P+MA++ + NG +CGG L+ ++VLTAAHC++
Sbjct: 1 IIGGREVIPHSRPYMASL-------QRNG--SHLCGGVLVHPKWVLTAAHCLAQRMAQLR 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKL-NDIALFRLREDAPLSDLIQPI 226
++ + ++D S G++ I+ I H +Y L N++AL +L S I+P+
Sbjct: 52 --LVLGLHTLD----SPGLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPL 105
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATI 286
LP R + +AGWG T G LS LR + + V+D C + ++
Sbjct: 106 ALPSK---RQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNN-SRFWNGSL 161
Query: 287 NENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTN 345
+ +++C PL+ + GV+S+ + C ++ P V T V
Sbjct: 162 SPSMVCLAADSKDQAPCKGDSGGPLV--CGKGRVLAGVLSFSSRVCTDIFKPPVATAVAP 219
Query: 346 YIQWI 350
Y+ WI
Sbjct: 220 YVSWI 224
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 73/246 (29%), Positives = 104/246 (42%), Gaps = 36/246 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + Q+P++A+I + G E CGGALI R+V+TAA C G
Sbjct: 1 IVGGRKARPRQFPFLASI-------QNQGSHE--CGGALIHARFVMTAASCFQSQNPGV- 50
Query: 168 EPYIVHVGSIDL--EDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
V +G+ DL + S + I + Y + LND+ L +L +A L+ +
Sbjct: 51 --STVVLGAYDLRRRERQSRQTFSISS-MSENGYDPQQNLNDLMLLQLDREANLTSSVTI 107
Query: 226 ICLPYDTNLRSELFERKTPF-VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
+ LP L++ E T VAGWGS G LS R V ++V +CR
Sbjct: 108 LPLP----LQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR-------- 155
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
N +C GVL PL+ + GV S+ G P +TRV
Sbjct: 156 ---PNNVCTGVLTRRGGICNGDGGTPLV----CEGLAHGVASFSLGPCGRG-PDFFTRVA 207
Query: 345 NYIQWI 350
+ WI
Sbjct: 208 LFRDWI 213
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG S P+MA + + + + CGG L+ + +VLTAAHC +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQ------SPAGQSRCGGFLVREDFVLTAAHCWGSNIN--- 51
Query: 168 EPYIVHVGSIDLE-DTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ +++ ++ I R I H QY NDI L +L + + P+
Sbjct: 52 ----VTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPV 107
Query: 227 CLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
LP R++ R VAGWG R + LR VQ+ V + +C +IF +Y
Sbjct: 108 ALP-----RAQEGLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDP 161
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
+C G PL+ G+VSYGK P V+TRV+
Sbjct: 162 ---RRQICVGDRRERKAAFKGDSGGPLL----CNNVAHGIVSYGKSSGVP--PEVFTRVS 212
Query: 345 NYIQWI 350
+++ WI
Sbjct: 213 SFLPWI 218
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 31/246 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG S P+MA + + + + CGG L+ + +VLTAAHC +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQ------SPAGQSRCGGFLVREDFVLTAAHCWGSNIN--- 51
Query: 168 EPYIVHVGSIDLE-DTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
V +G+ +++ ++ I R I H QY NDI L +L + + P+
Sbjct: 52 ----VTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPV 107
Query: 227 CLPYDTNLRSELFERKTPF--VAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
LP R++ R VAGWG R + LR VQ+ V + +C +IF +Y
Sbjct: 108 ALP-----RAQEGLRPGTLCTVAGWGRVSMRRG-TDTLREVQLRVQRDRQCLRIFGSYDP 161
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVT 344
+C G PL+ G+VSYGK P V+TRV+
Sbjct: 162 ---RRQICVGDRRERKAAFKGDSGGPLL----CNNVAHGIVSYGKSSGVP--PEVFTRVS 212
Query: 345 NYIQWI 350
+++ WI
Sbjct: 213 SFLPWI 218
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 140 WMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY 199
+ CG LI + +V+TAAHC D+T VH + ED + E+ I +
Sbjct: 23 YFCGLTLINQEWVVTAAHC---DSTNFQMQLGVHSKKVLNEDEQT--RNPKEKFICPNKN 77
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
S DI L +L + S I P+ LP + + + GWGS
Sbjct: 78 MSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPSVGSVCR-----IMGWGSITIPNETY 132
Query: 260 PKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTK 318
P + + I++VD C+ ++ A + LCAGVL PL+
Sbjct: 133 PDVPYCANINLVDYEVCQGAYNGLPA---KTTLCAGVLEGGKDTCVGDSGGPLI----CN 185
Query: 319 YYIIGVVSYGK-KCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VSYG C + PG+YT V +Y WI NI+
Sbjct: 186 GQFQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRNIA 223
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 140 WMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY 199
++CGG LI + +V+TAAHC D+ + VH I ED E R + +
Sbjct: 24 FLCGGTLINQDWVVTAAHC---DSNNFQLLFGVHSKKILNED-------EQTRDPKEKFF 73
Query: 200 TSARKLND-----IALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVF 254
RK +D I L +L S+ I P+ LP + + GWG T+
Sbjct: 74 CPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPLSLPSSPPSVGSVCR-----IMGWGKTIP 128
Query: 255 RGPLSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMY 313
+ P + H I+++D+ CR +S + LCAG+L PL+
Sbjct: 129 TKEIYPDVPHCANINILDHAVCRTAYS--WRQVANTTLCAGILQGGRDTCHFDSGGPLI- 185
Query: 314 PLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G C + G PGVYT+V +Y+ WI I+
Sbjct: 186 ---CNGIFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSIIA 225
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 24/243 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GGT P+MA + + C G LI + +V+TAAHC T
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSA-----CSGFLIRRNFVMTAAHCAGRSITVLL 55
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ V EDT +E+E+ H +Y LNDI L +L+E A L+ + +
Sbjct: 56 GAHNKKVK----EDTWQ--KLEVEKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLP 109
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
+ +N + + GWG T P S L+ V++ ++D C+ F ++
Sbjct: 110 ISAKSN---SIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKH-FEDFH---Q 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E LC G PL+ + G+ SY + A+ P V+TR+++Y
Sbjct: 163 EPQLCVGNPKKIRNVYKGDSGGPLLCAGIAQ----GIASYVLRNAKP--PSVFTRISHYR 216
Query: 348 QWI 350
WI
Sbjct: 217 PWI 219
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 49/151 (32%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+V +G E +S+ +E+ IH +Y L+ DIAL +L++ S
Sbjct: 54 FTENDLLVRIGKHSRTRYERNIEKISM-LEKIYIHPRYNWRENLDRDIALMKLKKPVAFS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS 251
D I P+CLP S L V GWG+
Sbjct: 113 DYIHPVCLPDRETAASLLQAGYKGRVTGWGN 143
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 67/257 (26%), Positives = 101/257 (39%), Gaps = 44/257 (17%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG E+ PW A+ E++CGG LI +V+TAAHC S +
Sbjct: 1 IVGGYKCEKNSQPWQVAV-----------INEYLCGGVLIDPSWVITAAHCYSNN----- 44
Query: 168 EPYIVHVGSIDL-EDTSSGVSIEIERPIIHEQYTSA-----------RKLNDIALFRLRE 215
Y V +G +L +D + + H Y ND+ L L E
Sbjct: 45 --YQVLLGRNNLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSE 102
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST-VFRGPLSPKLRHVQISVVDNPK 274
A ++ ++ I LP E T +GWGST +S L+ V I ++ N K
Sbjct: 103 PADITGGVKVIDLP-----TKEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEK 157
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAE 333
C Y + + +LCAG + PL+ + G+ S G CA+
Sbjct: 158 C---IETYKDNVTDVMLCAGEMEGGKDTCAGDSGGPLI----CDGVLQGITSGGATPCAK 210
Query: 334 VGFPGVYTRVTNYIQWI 350
P +Y ++ + WI
Sbjct: 211 PKTPAIYAKLIKFTSWI 227
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 42/146 (28%), Positives = 63/146 (43%), Gaps = 18/146 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IV G + G WPW ++ K CGG+LI + +V+TAAHC G
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFH--------FCGGSLINENWVVTAAHC------GVT 46
Query: 168 EPYIVHVGSIDLEDTSSGVS-IEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+V G D +S + ++I + + +Y S NDI L +L A S + +
Sbjct: 47 TSDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAV 106
Query: 227 CLPYDTNLRSELFERKTPFVAGWGST 252
CLP ++ + T GWG T
Sbjct: 107 CLPSASD---DFAAGTTCVTTGWGLT 129
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 48/151 (31%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV---SPDTT 164
IV G +E G PW + K E +CG +LI+ R+VLTAAHC+ D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCLLYPPWDKN 53
Query: 165 GEYEPYIVHVGS---IDLEDTSSGVSIEIERPIIHEQYTSARKLN-DIALFRLREDAPLS 220
+ +V +G E +S+ +++ IH +Y L+ DIAL +L+ LS
Sbjct: 54 FTVDDLLVRIGKHSRTRYERKVEKISM-LDKIYIHPRYNWKENLDRDIALLKLKRPIELS 112
Query: 221 DLIQPICLPYDTNLRSELFERKTPFVAGWGS 251
D I P+CLP L V GWG+
Sbjct: 113 DYIHPVCLPDKQTAAKLLHAGFKGRVTGWGN 143
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 42/261 (16%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG E+ PW A+ + + CGG L+ ++VLTAAHC+S D
Sbjct: 1 IIGGWECEKHSKPWQVAV---------YHQGHFQCGGVLVHPQWVLTAAHCMSDD----- 46
Query: 168 EPYIVHVGSIDL---EDTS-------SGVSIEIERPIIHEQYTSARK--LNDIALFRLRE 215
Y + +G +L EDT+ S + + + ++ ++Y +D+ L RL +
Sbjct: 47 --YQIWLGRHNLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQ 104
Query: 216 DAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGS-TVFRGPLSPKLRHVQISVVDNPK 274
A ++D ++ + LP E T + +GWG + F S L+ V++ + N K
Sbjct: 105 PARITDAVKILDLP-----TQEPKLGSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEK 159
Query: 275 CRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYG-KKCAE 333
C + Y + E +LCA L+ G+ S+G +CA+
Sbjct: 160 CARA---YPEKMTEFVLCATHRDDSGSICLGDSGGALI----CDGVFQGITSWGYSECAD 212
Query: 334 VGFPGVYTRVTNYIQWIADNI 354
V+T+V + +WI + I
Sbjct: 213 FNDNFVFTKVMPHKKWIKETI 233
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 68/253 (26%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+ G+ + PW AA+ R N + CG L+ +++LTAAHC
Sbjct: 1 IINGSDCDMHTQPWQAALLL-----RPN---QLYCGAVLVHPQWLLTAAHC-------RK 45
Query: 168 EPYIVHVGSIDLEDT--SSGVSIEIERPIIHEQYTSARKLNDIALFRL-REDAPLSDLIQ 224
+ + V +G L S + + I H Y+ ND+ L +L R P D ++
Sbjct: 46 KVFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKD-VR 104
Query: 225 PICLPYDTNLRSELFERKTP-FVAGWGSTVFRGPLSPK-LRHVQISVVDNPKCRQIFSNY 282
PI N+ S T V+GWG+T PK L+ + ISV+ +C Y
Sbjct: 105 PI------NVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDA---Y 155
Query: 283 GATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYT 341
I++ + CAG P+ + G+VS+G CA PGVYT
Sbjct: 156 PRQIDDTMFCAGDKAGRDSCQGDSGG-----PVVCNGSLQGLVSWGDYPCARPNRPGVYT 210
Query: 342 RVTNYIQWIADNI 354
+ + +WI + I
Sbjct: 211 NLCKFTKWIQETI 223
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 35/230 (15%)
Query: 134 ANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERP 193
ANG +CGG LI + +VLTA HC + +++G +L+ + + R
Sbjct: 20 ANGS---LCGGTLINQEWVLTARHC-------DRGNMRIYLGMHNLKVLNK----DALRR 65
Query: 194 IIHEQYTSARKLND------IALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVA 247
E+Y ND I L RL S I P+ LP + + +
Sbjct: 66 FPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCR-----IM 120
Query: 248 GWGSTVFRGPLSPKLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXX 306
GWG+ P + H I+++D C+ + AT LCAG+L
Sbjct: 121 GWGTITSPNATLPDVPHCANINILDYAVCQAAYKGLAATT----LCAGILEGGKDTCKGD 176
Query: 307 XXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
PL+ G++S G CA+ PG+YT+V +Y WI IS
Sbjct: 177 SGGPLI----CNGQFQGILSVGGNPCAQPRKPGIYTKVFDYTDWIQSIIS 222
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 69/252 (27%), Positives = 104/252 (41%), Gaps = 27/252 (10%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG S+ + PW A+G + KP CGG+++T +V+TAA CV +
Sbjct: 1 IIGGKKSDITKEPW--AVGVLVDE-----KP--FCGGSILTANFVITAAQCVDGTKPSDI 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSD-LIQPI 226
+H GS T+ G S+ + + I +Y N+ A+ L D + I
Sbjct: 52 S---IHYGS--SYRTTKGTSV-MAKKIYIVRYHPLTMQNNYAVIETEMPIKLDDKTTKKI 105
Query: 227 CLPYDTNLRSELFERKTPFVAGWGSTVFRG-PLSPKLRHVQISVVDNPKCRQIFSNYGAT 285
LP +L + + V+GWGST F+ S L +VVD C + + A
Sbjct: 106 ELP---SLLYDPEPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEAD 162
Query: 286 --INENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRV 343
I + + CAG P + ++GV SY FP V+ RV
Sbjct: 163 KYIYDGVFCAGGEYDETYIGYGDAGDPAV----QNGTLVGVASYISSMPS-EFPSVFLRV 217
Query: 344 TNYIQWIADNIS 355
Y+ I D IS
Sbjct: 218 GYYVLDIKDIIS 229
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 16/217 (7%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYT 200
CGG LI + +VLTAAHC D +H + ED + V E + + YT
Sbjct: 27 FCGGTLINQEWVLTAAHC---DRKNFRIKLGMHSKKVPNEDEQTRVPKEKFFCLSSKNYT 83
Query: 201 SARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSP 260
K DI L RL D+P+ + + + S + GWG P
Sbjct: 84 LWDK--DIMLIRL--DSPVKNSKH---IAPFSLPSSPPSVGSVCRIMGWGRISPTEGTYP 136
Query: 261 KLRH-VQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKY 319
+ H V I++++ CR + + LCAG+L PL+
Sbjct: 137 DVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCKGDSGGPLI----CNG 192
Query: 320 YIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
G+ S+G CA+ P YT+V +++ WI + I+
Sbjct: 193 QFQGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIA 229
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 20/219 (9%)
Query: 140 WMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY 199
+ CGG LI +V+TAAHC D+T VH + ED + E+ I +
Sbjct: 24 FFCGGTLINPEWVVTAAHC---DSTNFQMQLGVHSKKVLNEDEQT--RNPKEKFICPNKN 78
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+ DI L +L D P+S+ + + S + GWGS
Sbjct: 79 NNEVLDKDIMLIKL--DKPISNSKH---IAPLSLPSSPPSVGSVCRIMGWGSITPVKETF 133
Query: 260 PKLRH-VQISVVDNPKCRQIFSNYGATINE-NILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P + + I+++D+ C+ + Y + E LCAG++ PL+
Sbjct: 134 PDVPYCANINLLDHAVCQ---AGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLI----C 186
Query: 318 KYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
G+VSYG C + PG+YT V +Y WI NI+
Sbjct: 187 NGQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIA 225
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 55/243 (22%), Positives = 101/243 (41%), Gaps = 22/243 (9%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG P G PW ++ R R+ + CGG+L+ ++++LTA C S
Sbjct: 1 VVGGHP---GNSPWTVSL----RNRQG----QHFCGGSLVKEQWILTARQCFS-SCHMPL 48
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
Y V +G++ ++ G P+ + + + L +L L+ + IC
Sbjct: 49 TGYEVWLGTL-FQNPQHGEPSLQRVPV--AKMVCGPSGSQLVLLKLERSVTLNQRVALIC 105
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP + + + + +AGWG T G L ++V+ N +C + +
Sbjct: 106 LPPEWYVVPPGTKCE---IAGWGETKGTGN-DTVLNVALLNVISNQECN---IKHRGRVR 158
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKKCAEVGFPGVYTRVTNYI 347
E+ +C L PL + + G++ + CA +P V+TRV+ ++
Sbjct: 159 ESEMCTEGLLAPVGACEGDYGGPLACFTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFV 218
Query: 348 QWI 350
WI
Sbjct: 219 DWI 221
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 18/137 (13%)
Query: 117 GQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGS 176
G WPW ++ K CGG+LI++ +V+TAAHC G +V G
Sbjct: 7 GSWPWQVSLQDKTGFH--------FCGGSLISEDWVVTAAHC------GVKTSDVVVAGE 52
Query: 177 IDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLR 235
D + + +I + + ++ NDI L +L A S+ + +CLP N+
Sbjct: 53 FDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLP---NVD 109
Query: 236 SELFERKTPFVAGWGST 252
+ GWG T
Sbjct: 110 DDFPPGTVCATTGWGKT 126
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 20/219 (9%)
Query: 140 WMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY 199
+ CGG LI +V+TAAHC S D + VH + ED + E+ I +
Sbjct: 24 FFCGGTLINPEWVVTAAHCDSTDFQMQLG---VHSKKVLNEDEQT--RNPKEKFICPNKN 78
Query: 200 TSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLS 259
+ DI L +L D P+S+ + + S + GWGS
Sbjct: 79 NNEVLDKDIMLIKL--DKPISNSKH---IAPLSLPSSPPSVGSVCRIMGWGSITPVKETF 133
Query: 260 PKLRH-VQISVVDNPKCRQIFSNYGATINE-NILCAGVLXXXXXXXXXXXXXPLMYPLDT 317
P + + I+++D+ C+ + Y + E LCAG++ PL+
Sbjct: 134 PDVPYCANINLLDHAVCQ---AGYPELLAEYRTLCAGIVQGGKDTCGGDSGGPLI----C 186
Query: 318 KYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
G+VSYG C + PG+YT V +Y WI NI+
Sbjct: 187 NGQFQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRNIA 225
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 38/146 (26%), Positives = 60/146 (41%), Gaps = 18/146 (12%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IV G + G WPW ++ K CGG+LI++ +V+TAAHC G
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFH--------FCGGSLISEDWVVTAAHC------GVK 46
Query: 168 EPYIVHVGSIDLEDTSSGVSI-EIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPI 226
+V G D + + +I + + ++ NDI L +L A S+ + +
Sbjct: 47 TSDVVVAGEFDQGSDEENIQVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAV 106
Query: 227 CLPYDTNLRSELFERKTPFVAGWGST 252
LP N+ + GWG T
Sbjct: 107 SLP---NVDDDFPPGTVCATTGWGKT 129
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 35/251 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKP-EWMCGGALITKRYVLTAAHCVSPDTTGE 166
IVGG ++ P+MA++ + G P CGG LI +VLTAAHC+ D
Sbjct: 1 IVGGHEAQPHSRPYMASLQMR-------GNPGSHFCGGTLIHPSFVLTAAHCLR-DIPQR 52
Query: 167 YEPYIVHVGSIDLED-TSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQP 225
++ ++ ++ T S+ + Y + KLNDI L +L A LS +
Sbjct: 53 LVNVVLGAHNVRTQEPTQQHFSVA---QVFLNNYDAENKLNDILLIQLSSPANLSASVAT 109
Query: 226 ICLPYDTNLRSELFERKTPFVA-GWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGA 284
+ LP + + T +A GWG P + L+ + ++VV CR
Sbjct: 110 VQLPQ----QDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTF-FCR-------- 156
Query: 285 TINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRV 343
+ +C V PL+ I G+ S+ CA FP +TRV
Sbjct: 157 ---PHNICTFVPRRKAGICFGDSGGPLI----CDGIIQGIDSFVIWGCATRLFPDFFTRV 209
Query: 344 TNYIQWIADNI 354
Y+ WI +
Sbjct: 210 ALYVDWIRSTL 220
>pdb|2IKD|A Chain A, Solution Structure Of The First Clip Domain In Pap2
Length = 66
Score = 51.6 bits (122), Expect = 7e-07, Method: Composition-based stats.
Identities = 20/54 (37%), Positives = 33/54 (61%)
Query: 10 CSTPRNEIGTCISIRQCRYLYDILNNERNNPRAVQYVKNSHCGLEGRLPKVCCP 63
C+ P N+ GTC S+ QC I++ + + ++++ S CG +G+ PKVCCP
Sbjct: 13 CTLPNNDKGTCKSLLQCDVASKIISKKPRTAQDEKFLRESACGFDGQTPKVCCP 66
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 66/253 (26%), Positives = 101/253 (39%), Gaps = 33/253 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
+VGG + P++ A+ + C GALI + +VLTAAHC D
Sbjct: 1 VVGGDECNINEHPFLVAL-------YTSASSTIHCAGALINREWVLTAAHC---DRRNIR 50
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERP---IIHEQYTSARKLNDIALFRLREDAPLSDLIQ 224
+H +I ED I + R ++ ++ + DI L RLR S I
Sbjct: 51 IKLGMHSKNIRNEDEQ----IRVPRGKYFCLNTKFPNGLD-KDIMLIRLRRPVTYSTHIA 105
Query: 225 PICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRH-VQISVVDNPKCRQIFSNYG 283
P+ LP RS + + GWG P + H I +V + C ++
Sbjct: 106 PVSLPS----RSRGVGSRC-RIMGWGK--ISTTTYPDVPHCTNIFIVKHKWCEPLYPWVP 158
Query: 284 ATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTR 342
A + LCAG+L PL+ + G+V+ G + C + P VYT+
Sbjct: 159 A--DSRTLCAGILKGGRDTCHGDSGGPLICNGEMH----GIVAGGSEPCGQHLKPAVYTK 212
Query: 343 VTNYIQWIADNIS 355
V +Y WI I+
Sbjct: 213 VFDYNNWIQSIIA 225
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI 321
L+ ++ V+ N C+ S+Y I N++C G L P++ +
Sbjct: 10 LQCLKAPVLSNSSCK---SSYPGQITGNMICVGFLQGGKDSCQGDSGGPVV----CNGQL 62
Query: 322 IGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 63 QGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 96
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 206 NDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGP----LSPK 261
+D+ L RL+ A ++D ++ + LP EL T +GWGS + GP +
Sbjct: 8 HDLMLLRLQSPAKITDAVKVLELP---TQEPEL--GSTCEASGWGS-IEPGPDDFEFPDE 61
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI 321
++ VQ++++ N C + + E++LCAG L PL+
Sbjct: 62 IQCVQLTLLQNTFCADAHPD---KVTESMLCAGYLPGGKDTCMGDSGGPLI----CNGMW 114
Query: 322 IGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
G+ S+G C P +YT++ Y+ WI D I+
Sbjct: 115 QGITSWGHTPCGSANKPSIYTKLIFYLDWIDDTIT 149
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYI 321
L+ ++ V+ + C+ S+Y I N++C G L P++ +
Sbjct: 10 LQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVV----CNGQL 62
Query: 322 IGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
G+VS+G CA+ PGVYT+V NY+ WI I+
Sbjct: 63 QGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIA 96
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 91/225 (40%), Gaps = 32/225 (14%)
Query: 140 WMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQY 199
+ C G LI + +VLTAAHC D T VH + ED + P E++
Sbjct: 24 FFCSGTLINEEWVLTAAHC---DNTNFQMKLGVHSKKVLNEDEQT------RNP--KEKF 72
Query: 200 TSARKLN------DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTV 253
K N DI L +L S+ I P+ LP + + GWGS
Sbjct: 73 ICPNKKNDEVLDKDIMLIKLDSRVSNSEHIVPLSLPSSPPSVGSVCH-----IMGWGSIT 127
Query: 254 FRGPLSPKLRHVQ-ISVVDNPKCRQIFSNYGATINE-NILCAGVLXXXXXXXXXXXXXPL 311
P + + I+++D+ C+ + Y + E LCAG+L PL
Sbjct: 128 PIKVTYPDVPYCAYINLLDDAVCQ---AGYPELLTEYRTLCAGILEGGKDTCGGDSGGPL 184
Query: 312 MYPLDTKYYIIGVVSYGKK-CAEVGFPGVYTRVTNYIQWIADNIS 355
+ G+VS+G C + PGVYT+V +Y WI I+
Sbjct: 185 I----CNGQFQGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQSIIA 225
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 109 VGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYE 168
+ S++ + PW I K + C GALI+ ++VLTAAHC ++
Sbjct: 233 MSANASDQERTPWHVTI---------KPKSQETCRGALISDQWVLTAAHCFRDGN--DHS 281
Query: 169 PYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPL 219
+ V+VG + G IE+ +I + K N DIAL +L + +
Sbjct: 282 LWRVNVGD---PKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKM 338
Query: 220 SDLIQPICLP 229
S +PICLP
Sbjct: 339 STHARPICLP 348
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 109 VGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYE 168
+ S++ + PW I K + C GALI+ ++VLTAAHC ++
Sbjct: 225 MSANASDQERTPWHVTI---------KPKSQETCRGALISDQWVLTAAHCFRDGN--DHS 273
Query: 169 PYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPL 219
+ V+VG + G IE+ +I + K N DIAL +L + +
Sbjct: 274 LWRVNVGD---PKSQWGKEFLIEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKM 330
Query: 220 SDLIQPICLP 229
S +PICLP
Sbjct: 331 STHARPICLP 340
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 227 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 272
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 273 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 331
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 235 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 280
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 281 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 339
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 460 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 505
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 506 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 564
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 469 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 514
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 515 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 573
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 479 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 524
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 525 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 583
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 35/119 (29%), Positives = 50/119 (42%), Gaps = 23/119 (19%)
Query: 120 PWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEYEPYIVHVGSIDL 179
PW A I IR + + C GA++++ +VLTAAHC + D SI +
Sbjct: 28 PWQAKISV-IRPSKGHES----CMGAVVSEYFVLTAAHCFTVDDKEH---------SIKV 73
Query: 180 EDTSSGVSIEIERPIIHEQYTSARKLN---------DIALFRLREDAPLSDLIQPICLP 229
+EIE + H Y K D+AL +L+ I+PICLP
Sbjct: 74 SVGGEKRDLEIEVVLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 132
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 44.7 bits (104), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 57/244 (23%), Positives = 93/244 (38%), Gaps = 32/244 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP+M ++ + A G CG LI +V++AAHCV+
Sbjct: 1 IVGGRRARPHAWPFMVSL------QLAGGH---FCGATLIAPNFVMSAAHCVANVNVRAV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ G+ +L + + I + Y LNDI + +L A ++ +Q
Sbjct: 52 RVVL---GAHNLSRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP L GWG ++ L+ + ++VV + CR+ SN +
Sbjct: 109 LPAQGR---RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRR--SNVCTLVR 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTNY 346
AGV PL I G+ S+ + CA +P + V +
Sbjct: 163 GRQ--AGVCFGDSGS-----------PLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 347 IQWI 350
+ WI
Sbjct: 210 VNWI 213
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 55/244 (22%), Positives = 91/244 (37%), Gaps = 32/244 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP+M ++ + CG LI +V++AAHCV+
Sbjct: 1 IVGGRRARPHAWPFMVSLQLR---------GGHFCGATLIAPNFVMSAAHCVANVNVRAV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ G+ +L + + I + Y LNDI + +L A ++ +Q
Sbjct: 52 RVVL---GAHNLSRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP L GWG ++ L+ + ++VV + CR+ SN +
Sbjct: 109 LPAQGR---RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRR--SNVCTLVR 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTNY 346
AGV PL I G+ S+ + CA +P + V +
Sbjct: 163 GRQ--AGVCFGDSGS-----------PLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 347 IQWI 350
+ WI
Sbjct: 210 VNWI 213
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 54/115 (46%), Gaps = 17/115 (14%)
Query: 141 MCGGALITKRYVLTAAHCVSPDTTGEYEPYI-VHVG--SIDLEDTSSGVSIEIERPIIHE 197
CGG+LI ++V++AAHC Y+ I V +G +ID+ + + I + I H
Sbjct: 24 FCGGSLINSQWVVSAAHC--------YKSRIQVRLGEHNIDVLEGNEQF-INAAKIITHP 74
Query: 198 QYTSARKLNDIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGST 252
+ NDI L +L A L+ + + LP RS ++GWG+T
Sbjct: 75 NFNGNTLDNDIMLIKLSSPATLNSRVATVSLP-----RSCAAAGTECLISGWGNT 124
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 43.9 bits (102), Expect = 2e-04, Method: Composition-based stats.
Identities = 22/95 (23%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
+L+ + ++ N C++ +G I + ++CAG PL+ + +
Sbjct: 6 RLQQASLPLLSNTNCKKY---WGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWT 60
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++G+VS+G PGVY RVT + W+ ++
Sbjct: 61 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA 95
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 43.9 bits (102), Expect = 2e-04, Method: Composition-based stats.
Identities = 22/95 (23%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
+L+ + ++ N C++ +G I + ++CAG PL+ + +
Sbjct: 5 RLQQASLPLLSNTNCKKY---WGTKIKDAMICAGA--SGVSSCMGDSGGPLVCKKNGAWT 59
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++G+VS+G PGVY RVT + W+ ++
Sbjct: 60 LVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTLA 94
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/244 (22%), Positives = 90/244 (36%), Gaps = 32/244 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP+M ++ + CG LI +V++AAHCV+
Sbjct: 1 IVGGRRARPHAWPFMVSLQLR---------GGHFCGATLIAPNFVMSAAHCVANVNVRAV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ G+ +L + + I Y LNDI + +L A ++ +Q
Sbjct: 52 RVVL---GAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP L GWG ++ L+ + ++VV + CR+ SN +
Sbjct: 109 LPAQGR---RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRR--SNVCTLVR 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTNY 346
AGV PL I G+ S+ + CA +P + V +
Sbjct: 163 GRQ--AGVCFGDSGS-----------PLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 347 IQWI 350
+ WI
Sbjct: 210 VNWI 213
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/244 (22%), Positives = 90/244 (36%), Gaps = 32/244 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP+M ++ + CG LI +V++AAHCV+
Sbjct: 1 IVGGRRARPHAWPFMVSLQLR---------GGHFCGATLIAPNFVMSAAHCVANVNVRAV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ G+ +L + + I Y LNDI + +L A ++ +Q
Sbjct: 52 RVVL---GAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP L GWG ++ L+ + ++VV + CR+ SN +
Sbjct: 109 LPAQGR---RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRR--SNVCTLVR 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTNY 346
AGV PL I G+ S+ + CA +P + V +
Sbjct: 163 GRQ--AGVCFGDSGS-----------PLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 347 IQWI 350
+ WI
Sbjct: 210 VNWI 213
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 56/244 (22%), Positives = 91/244 (37%), Gaps = 32/244 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
IVGG + WP+M ++ + CG LI +V++AAHCV+
Sbjct: 1 IVGGRRARPHAWPFMVSLQLR---------GGHFCGATLIAPNFVMSAAHCVANVNVRAV 51
Query: 168 EPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRLREDAPLSDLIQPIC 227
+ G+ +L + + I Y LNDI + +L A ++ +Q
Sbjct: 52 RVVL---GAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQ 108
Query: 228 LPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNPKCRQIFSNYGATIN 287
LP L GWG ++ L+ + ++VV + CR+ SN +
Sbjct: 109 LPAQGR---RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTS-LCRR--SNVCTLVR 162
Query: 288 ENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYYIIGVVSYGK-KCAEVGFPGVYTRVTNY 346
AGV PL I G+ S+ + CA +P + V +
Sbjct: 163 GRQ--AGVCFGDXGS-----------PLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQF 209
Query: 347 IQWI 350
+ WI
Sbjct: 210 VNWI 213
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 41.6 bits (96), Expect = 6e-04, Method: Composition-based stats.
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 5/90 (5%)
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
KL+ + +V C++ ++G+ I + + CAG PL+ D +
Sbjct: 8 KLQQAALPIVSEADCKK---SWGSKITDVMTCAGA--SGVDSCMGDSGGPLVCQKDGVWT 62
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
+ G+VS+G PGVY+RVT + W+
Sbjct: 63 LAGIVSWGSGVCSTSTPGVYSRVTALMPWV 92
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 38/187 (20%), Positives = 68/187 (36%), Gaps = 22/187 (11%)
Query: 94 NNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVL 153
+++C S KR P + + ++++ + GK CGG +I + +VL
Sbjct: 85 HDQCACGVLTSEKRA-----------PDLQDLPWQVKLTNSEGKD--FCGGVIIRENFVL 131
Query: 154 TAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRL 213
T A C + Y L I+I +H +Y + ND++L L
Sbjct: 132 TTAKCSLLHRNITVKTYFNRTSQDPL-------MIKITHVHVHMRYDADAGENDLSLLEL 184
Query: 214 REDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNP 273
P+C P L R ++GW L L +++V+
Sbjct: 185 EWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARN--GTDLGNSLTTRPVTLVEGE 242
Query: 274 KCRQIFS 280
+C Q+ +
Sbjct: 243 ECGQVLN 249
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/187 (19%), Positives = 69/187 (36%), Gaps = 22/187 (11%)
Query: 94 NNECGVNAFNSSKRIVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVL 153
+++C S KR P + + ++++ + GK CGG +I + +VL
Sbjct: 44 HDQCACGVLTSEKRA-----------PDLQDLPWQVKLTNSEGKD--FCGGVIIRENFVL 90
Query: 154 TAAHCVSPDTTGEYEPYIVHVGSIDLEDTSSGVSIEIERPIIHEQYTSARKLNDIALFRL 213
T A C + Y + + I+I +H +Y + ND++L L
Sbjct: 91 TTAKCSLLHRNITVKTYFNRT-------SQDPLMIKITHVHVHMRYDADAGENDLSLLEL 143
Query: 214 REDAPLSDLIQPICLPYDTNLRSELFERKTPFVAGWGSTVFRGPLSPKLRHVQISVVDNP 273
P+C P L R ++GW L L +++V+
Sbjct: 144 EWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARN--GTDLGNSLTTRPVTLVEGE 201
Query: 274 KCRQIFS 280
+C Q+ +
Sbjct: 202 ECGQVLN 208
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 1/63 (1%)
Query: 190 IERPIIHEQYTSARKLN-DIALFRLREDAPLSDLIQPICLPYDTNLRSELFERKTPFVAG 248
+E+ IH +Y L+ DIAL +L++ SD I P+CLP S L V G
Sbjct: 8 LEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTG 67
Query: 249 WGS 251
WG+
Sbjct: 68 WGN 70
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 29/52 (55%), Gaps = 7/52 (13%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCV 159
IV G+ +E G PW + K E +CG +LI+ R+VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRK-------SPQELLCGASLISDRWVLTAAHCL 45
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 39.7 bits (91), Expect = 0.003, Method: Composition-based stats.
Identities = 26/88 (29%), Positives = 41/88 (46%), Gaps = 15/88 (17%)
Query: 108 IVGGTPSERGQWPWMAAIGFKIRRRRANGKPEWMCGGALITKRYVLTAAHCVSPDTTGEY 167
I+GG E+ PW AI + CGG L+ ++VLTAAHC + + Y
Sbjct: 1 IIGGRECEKNSHPWQVAI---------YHYSSFQCGGVLVNPKWVLTAAHCKNDN----Y 47
Query: 168 EPYIVHVGSIDLEDTSS--GVSIEIERP 193
E ++ + E+T+ GV+ + P
Sbjct: 48 EVWLGRHNLFENENTAQFFGVTADFPHP 75
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 39.7 bits (91), Expect = 0.003, Method: Composition-based stats.
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 261 KLRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXPLMYPLDTKYY 320
KL+ + +V C++ ++G+ I + + CAG PL+ D +
Sbjct: 8 KLQQAALPIVSEADCKK---SWGSKITDVMTCAGA--SGVDSCMGDSGGPLVCQKDGVWT 62
Query: 321 IIGVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
+ G+VS+G P VY+RVT + W+
Sbjct: 63 LAGIVSWGSGVCSTSTPAVYSRVTALMPWV 92
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLD 316
L+ V + +V+ P C+ + I +N+ CAG + P +
Sbjct: 6 LQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 62
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNIS 355
++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 63 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 101
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 36.6 bits (83), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 8/98 (8%)
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLD 316
L+ V + +V+ P C+ ++ I +N+ CAG + P +
Sbjct: 10 LQVVNLPLVERPVCK---ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYN 66
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWIADNI 354
++Y +G+VS+G+ C G G YT V +WI I
Sbjct: 67 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 104
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 35.8 bits (81), Expect = 0.034, Method: Composition-based stats.
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 8/94 (8%)
Query: 262 LRHVQISVVDNPKCRQIFSNYGATINENILCAGVLXXXXXXXXXXXXXP-----LMYPLD 316
L+ V + +V+ P C+ + I +N+ CAG + P +
Sbjct: 6 LQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN 62
Query: 317 TKYYIIGVVSYGKKCAEVGFPGVYTRVTNYIQWI 350
++Y +G+VS+G+ C G G YT V +WI
Sbjct: 63 NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
>pdb|3VJZ|A Chain A, Crystal Structure Of The Dna Mimic Protein Dmp19
pdb|3VJZ|B Chain B, Crystal Structure Of The Dna Mimic Protein Dmp19
Length = 166
Score = 31.2 bits (69), Expect = 0.83, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 246 VAGWGSTVFRGPLSPKLRHVQISVVDN--PKCRQIFSNYGATIN 287
+G+G +FR PL+ LR +I V K + ++ +G TI
Sbjct: 69 ASGYGEYIFRNPLADSLRRWKIKAVPKVLDKAKALYEQHGKTIE 112
>pdb|2IKE|A Chain A, Solution Structure Of The Second Clip Domain In Pap2
Length = 54
Score = 30.4 bits (67), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 10 CSTPRNEIGTCISIRQCRYLYDILNNERNNPRAVQYVKNSHCG 52
C TP N+ G C++I++C +L +I + Y+KNS C
Sbjct: 3 CLTPDNKPGKCVNIKKCTHLAEIEEDPIGEDETT-YLKNSVCA 44
>pdb|2HNH|A Chain A, Crystal Structure Of The Catalytic Alpha Subunit Of E.
Coli Replicative Dna Polymerase Iii
Length = 910
Score = 29.3 bits (64), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 10/21 (47%), Positives = 14/21 (66%)
Query: 333 EVGFPGVYTRVTNYIQWIADN 353
++GFPG + V +IQW DN
Sbjct: 334 QMGFPGYFLIVMEFIQWSKDN 354
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 29.3 bits (64), Expect = 3.5, Method: Composition-based stats.
Identities = 10/17 (58%), Positives = 15/17 (88%)
Query: 142 CGGALITKRYVLTAAHC 158
CGG+LI ++V++AAHC
Sbjct: 25 CGGSLINSQWVVSAAHC 41
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.138 0.438
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 10,558,842
Number of Sequences: 62578
Number of extensions: 414568
Number of successful extensions: 1754
Number of sequences better than 100.0: 358
Number of HSP's better than 100.0 without gapping: 349
Number of HSP's successfully gapped in prelim test: 9
Number of HSP's that attempted gapping in prelim test: 602
Number of HSP's gapped (non-prelim): 363
length of query: 355
length of database: 14,973,337
effective HSP length: 100
effective length of query: 255
effective length of database: 8,715,537
effective search space: 2222461935
effective search space used: 2222461935
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)